{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:36:09Z","timestamp":1791048969092,"version":"4.1.0"},"reference-count":656,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"Objective<\/jats:title>The emergence of resistance to colistin, the last resort for treating severe infections caused byPseudomonas aeruginosa<\/jats:italic>, poses a significant threat to public health. This meta-analysis aimed to investigate the prevalence of colistin resistance in clinical isolates ofP. aeruginosa.<\/jats:italic><\/jats:p><\/jats:sec>Method<\/jats:title>A comprehensive search of MEDLINE (PubMed), Web of Science, and Scopus databases was conducted to identify relevant articles published until December 2023. Subsequently, a meta-analysis was performed using Stata software to examine the pooled prevalence of colistin resistance and to conduct subgroup analyses.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 619 studies were included in the meta-analysis, revealing a global prevalence of colistin resistance of 1% among allP. aeruginosa<\/jats:italic>isolates. Furthermore, cystic fibrosis patients exhibited the highest resistance to colistin, with a prevalence of 7% among the examined diseases.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The increase in colistin resistance inP. aeruginosa<\/jats:italic>in recent years from 2% (in the period of 2006\u20132010) to 5% (in the period of 2020\u20132023) underscores the need for implementing infection prevention programs, using appropriate treatment regimens, and disseminating comprehensive information on antimicrobial resistance patterns. These measures are crucial for addressing this growing public health concern.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1477836","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:51:38Z","timestamp":1728449498000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Negar","family":"Narimisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbasali","family":"Keshtkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Dadgar-Zankbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjess","family":"Bostanghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman Rouein","family":"Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Shahroodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed","family":"Zahedi Bialvaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.genrep.2021.101301","article-title":"Evaluation of efflux pumps overexpression and \u03b2-lactamase genes among colistin resistant Pseudomonas aeruginosa","volume":"24","author":"Abavisani","year":"2021","journal-title":"Gene Rep."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/IDR.S238811","article-title":"Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa","volume":"13","author":"Abd El-Baky","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/antibiotics12101514","article-title":"Antibacterial and anti-efflux activities of cinnamon essential oil against pan and extensive drug-resistant Pseudomonas aeruginosa isolated from human and animal sources","volume":"12","author":"Abdelatti","year":"2023","journal-title":"Antibiotics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1007\/s11033-021-06820-0","article-title":"Molecular detection of gyrA and mexA genes in Pseudomonas aeruginosa","volume":"48","author":"Abed","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/tropicalmed7120415","article-title":"Treatments and predictors of mortality for carbapenem-resistant gram-negative bacilli infections in Malaysia: a retrospective cohort study","volume":"7","author":"Abubakar","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"ref6","article-title":"Antimicrobial resistance patterns and phenotypic-\u03b2lactamases detection of MDR Pseudomonas aeruginosa isolates from wounds and burns of Iraqi patients","volume":"20","author":"Abulzahra","year":"2020","journal-title":"Biochem. Cell. Arch."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.2147\/IDR.S327652","article-title":"Occurrence of multiple, extensive and Pan drug-resistant Pseudomonas aeruginosa and Carbapenemase production from presumptive isolates stored in a biobank at Ethiopian Public Health Institute","volume":"14","author":"Addis","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/0971-7749.108149","article-title":"Microbiological profile and their antimicrobial sensitivity pattern in patients of otitis media with ear discharge","volume":"19","author":"Agrawal","year":"2013","journal-title":"Indian J. Otol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0172882","DOI":"10.1371\/journal.pone.0172882","article-title":"Identification of extensive drug resistant Pseudomonas aeruginosa strains: new clone ST1725 and high-risk clone ST233","volume":"12","author":"Aguilar-Rodea","year":"2017","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.29252\/iem.6.3.211","article-title":"Incidence of multidrug-resistant, extensively drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa strains isolated from clinical specimens","volume":"6","author":"Ahani Azari","year":"2020","journal-title":"Infect. Epidemiol. Microbiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1017\/ash.2022.226","article-title":"Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar","volume":"2","author":"Ahmed","year":"2022","journal-title":"Antimicrobial Stewardship Healthcare Epidemiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.infpip.2019.100027","article-title":"Emergence of multidrug-and pandrug-resistant Pseudomonas aeruginosa from five hospitals in Qatar","volume":"1","author":"Ahmed","year":"2019","journal-title":"Infect. Prevent. Pract."},{"key":"ref13","first-page":"13","article-title":"Incidence of urinary tract infections (UTI) among children and adolescents in Ile-Ife, Nigeria","volume":"1","author":"Aiyegoro","year":"2007","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5505\/ejm.2021.03880","article-title":"Phenotypic and genotypic analysis of the antibiotic resistance profiles of gram negative Bacteria isolated from the blood culture samples","volume":"26","author":"Akg\u00fcl","year":"2021","journal-title":"Eastern J. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e20309","DOI":"10.5812\/jjm.20309v2","article-title":"Antibiotic susceptibility pattern of aerobic and anaerobic Bacteria isolated from surgical site infection of hospitalized patients","volume":"8","author":"Akhi","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"ref16","first-page":"962","article-title":"Incidence, characterization and anti-microbial susceptibility pattern of Pseudomonas aeruginosa isolated from clinical subjects","volume":"13","author":"Akram","year":"2022","journal-title":"Bacteriology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18683\/germs.2018.1130","article-title":"Antimicrobial resistance and putative virulence genes of Pseudomonas aeruginosa isolates from patients with respiratory tract infection","volume":"8","author":"Al Dawodeyah","year":"2018","journal-title":"Germs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1179\/1120009X12Z.00000000015","article-title":"Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia","volume":"24","author":"Al-Agamy","year":"2012","journal-title":"J. Chemother."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijso.2020.12.010","article-title":"Prevalence of multidrug resistance bacterial isolates from infected wound patients in Dhaka, Bangladesh: a cross-sectional study","volume":"28","author":"Alam","year":"2021","journal-title":"Int. J. Surg. Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3855\/jidc.14176","article-title":"Carbapenem and colistin-resistant bacteria in North Lebanon: coexistence of mcr-1 and NDM-4 genes in Escherichia coli","volume":"15","author":"Al-Bayssari","year":"2021","journal-title":"J. Infect. Dev. Countries"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e15007","DOI":"10.7717\/peerj.15007","article-title":"Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic","volume":"11","author":"Alc\u00e1ntar-Curiel","year":"2023","journal-title":"PeerJ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","article-title":"Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia","volume":"22","author":"Alexopoulou","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jacamr\/dlac035","article-title":"Evaluation of in vitro activity of ceftolozane\/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane\/tazobactam: data from Kuwait and Oman","volume":"4","author":"Alfouzan","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/pathogens7030075","article-title":"In vitro activity of newer and conventional antimicrobial agents, including Fosfomycin and Colistin, against selected gram-negative Bacilli in Kuwait","volume":"7","author":"Alfouzan","year":"2018","journal-title":"Pathogens"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkp281","article-title":"In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis","volume":"64","author":"Alhanout","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.17582\/journal.pjz\/20190712160705","article-title":"Diversity of extended Spectrum \u03b2-lactamases among multi drug resistant clinical isolates of Pseudomonas aeruginosa collected fromTertiary care hospitals of Peshawar, Pakistan","volume":"53","author":"Ali","year":"2021","journal-title":"Pakistan J. Zool."},{"key":"ref27","first-page":"12","article-title":"Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals","volume":"65","author":"Ali","year":"2015","journal-title":"J. Pak. Med. Assoc."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.5897\/AJMR11.284","article-title":"Antimicrobial resistance pattern of clinical isolates of Pseudomonas aeruginosa in the University of Malaya Medical Center, Malaysia","volume":"5","author":"Al-Kabsi","year":"2011","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/mdr.2019.0243","article-title":"Prevalence of genes involved in colistin resistance in Acinetobacter baumannii: first report from Iraq","volume":"26","author":"Al-Kadmy","year":"2020","journal-title":"Microb. Drug Resist."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.22207\/JPAM.16.3.12","article-title":"Genetic identification of Pseudomonas aeruginosa virulence genes associated with keratitis in Egyptian population","volume":"16","author":"Al-kaffas","year":"2022","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100661","DOI":"10.1016\/j.nmni.2020.100661","article-title":"Prevalence of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from diabetic foot infections in Iraq","volume":"35","author":"Al-Khudhairy","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.18502\/ijm.v15i1.11917","article-title":"Prevalence and molecular analysis of antibiotic resistance of Pseudomonas aeruginosa isolated from clinical and environmental specimens in Basra, Iraq","volume":"15","author":"Alkhulaifi","year":"2023","journal-title":"Iranian J. Microbiol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e00202","DOI":"10.1128\/mSphere.00202-21","article-title":"Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the Middle East and North Africa region","volume":"6","author":"Al-Orphaly","year":"2021","journal-title":"Msphere"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e280922209238","DOI":"10.2174\/1871526522666220928115043","article-title":"Resistance pattern in mostly gram-negative Bacteria causing urinary tract infections","volume":"23","author":"Alotaibi","year":"2023","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref35","article-title":"Phenotypic and molecular characterization of Carbapenemase-producing gram-negative isolates detected from wound infections","author":"Alruways","year":"2023","journal-title":"Medical Forum Monthly"},{"key":"ref36","first-page":"1256","article-title":"Improvement rapid molecular detection of Pseudomonas aeruginosa infected some Iraqi patients and It's antimicrobial susceptibility","volume":"7","author":"Al-shimmary","year":"2018","journal-title":"Res. J. Pharm., Biol. Chem. Sci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/1120009X.2020.1785741","article-title":"Dissemination of VIM-producing Pseudomonas aeruginosa associated with high-risk clone ST654 in a tertiary and quaternary hospital in Makkah, Saudi Arabia","volume":"33","author":"Al-Zahrani","year":"2021","journal-title":"J. Chemother."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/mdr.2015.0218","article-title":"Selection of amikacin hyper-resistant Pseudomonas aeruginosa after stepwise exposure to high amikacin concentrations","volume":"23","author":"Amabile-Cuevas","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/jac\/dkz493","article-title":"In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18","volume":"75","author":"Appalaraju","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"114884","DOI":"10.1016\/j.diagmicrobio.2019.114884","article-title":"In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant gram-negative isolates","volume":"95","author":"Aprile","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/MS9.0000000000000778","article-title":"Resistance patterns of bacterial pathogens causing lower respiratory tract infections: Aleppo-Syria","volume":"85","author":"Arab","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/mdr.2019.0214","article-title":"Occurrence and diversity of intra-and Interhospital drug-resistant and biofilm-forming Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"26","author":"Ara\u00fajo Lima","year":"2020","journal-title":"Microb. Drug Resist."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jac\/dkaa396","article-title":"Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam during treatment of XDR Pseudomonas aeruginosa infections","volume":"76","author":"Arca-Su\u00e1rez","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(15)00541-1","article-title":"Dissemination of the mcr-1 colistin resistance gene","volume":"16","author":"Arcilla","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.4274\/mjima.galenos.2023.2023.14","article-title":"Comparison of broth microdilution and Colistin disk elution methods for the determination of Colistin susceptibility in multidrug resistant Pseudomonas aeruginosa isolates","author":"Arici","year":"2023","journal-title":"Mediterr J Infect Microb Antimicrob"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.12669\/pjms.38.4.5221","article-title":"Identification of colistin resistance and its bactericidal activity against uropathogenic gram negative bacteria from Hayatabad medical complex Peshawar","volume":"38","author":"Arif","year":"2022","journal-title":"Pakistan J. Med. Sci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/microorganisms8010086","article-title":"When combined with Colistin, an otherwise ineffective rifampicin-linezolid combination becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii","volume":"8","author":"Armengol","year":"2020","journal-title":"Microorganisms"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2147\/IDR.S207844","article-title":"Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery","volume":"12","author":"Armengol","year":"2019","journal-title":"Infect Drug Resist."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4510-5","article-title":"Bla VIM-and Bla OXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda","volume":"19","author":"Aruhomukama","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e0217468","DOI":"10.1371\/journal.pone.0217468","article-title":"Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods","volume":"14","author":"Asar","year":"2019","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1590\/1806-9282.20210745","article-title":"Secondary bacterial infections in patients with coronavirus disease 2019-associated pneumonia","volume":"68","author":"Aydemir","year":"2022","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhin.2017.11.014","article-title":"Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections","volume":"98","author":"Ayd\u0131n","year":"2018","journal-title":"J. Hosp. Infect."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"Doc04","DOI":"10.3205\/dgkh000264","article-title":"Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran","volume":"11","author":"Azimi","year":"2016","journal-title":"GMS Hyg Infect. Control."},{"key":"ref55","first-page":"74","article-title":"KPC-producer gram negative bacteria among burned infants in Motahari hospital, Tehran: first report from Iran","volume":"25","author":"Azimi","year":"2012","journal-title":"Ann. Burns Fire Disasters"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e36160","DOI":"10.5812\/pedinfect.36160","article-title":"Comparison of efflux pump involvement in antibiotic resistance among Pseudomonas aeruginosa isolates of burn and non-burn patients","volume":"4","author":"Azimi","year":"2016","journal-title":"Arch. Pediatric Infect. Dis."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5530\/jyp.2018.10.79","article-title":"Prevalence of antimicrobial resistant pathogens in severe sepsis and septic shock patients","volume":"10","author":"Babu","year":"2018","journal-title":"J. Young Pharm."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12941-023-00597-9","article-title":"Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime\/colistin versus gentamicin\/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm","volume":"22","author":"Badawy","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref59","volume-title":"The prevalence of antibiotic-resistant bacterial nasal carriage at a Saudi university hospital","author":"Badierah","year":"2019"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"115553","DOI":"10.1016\/j.diagmicrobio.2021.115553","article-title":"In vitro activity of ceftazidime-avibactam and comparators against bacterial isolates collected in South Korea as part of the ATLAS global surveillance program (2016-2018)","volume":"102","author":"Bae","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jac\/dkz552","article-title":"Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa","volume":"75","author":"Baek","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.18683\/germs.2017.1117","article-title":"Multidrug and co-resistance patterns of non-fermenting gram-negative bacilli involved in ventilator-associated pneumonia carrying class 1 integron in the north of Iran","volume":"7","author":"Bagheri-Nesami","year":"2017","journal-title":"Germs"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jiph.2022.02.009","article-title":"In-vitro activity of ceftolozane\/tazobactam against recent clinical bacterial isolates from two Saudi Arabian hospitals","volume":"15","author":"Bahabri","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18502\/ijm.v11i1.701","article-title":"Molecular detection of virulence factors and biofilm formation in Pseudomonas aeruginosa obtained from different clinical specimens in Bandar Abbas","volume":"11","author":"Bahador","year":"2019","journal-title":"Iranian J. Microbiol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"105409","DOI":"10.1016\/j.micpath.2022.105409","article-title":"Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions","volume":"164","author":"Bah\u00e7e","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/pathogens12030426","article-title":"Genome analysis of Pseudomonas aeruginosa strains from chronically infected patients with high levels of persister formation","volume":"12","author":"Baiomy","year":"2023","journal-title":"Pathogens"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12866-022-02524-y","article-title":"Phenotype and genetic determination of resistance to common disinfectants among biofilm-producing and non-producing Pseudomonas aeruginosa strains from clinical specimens in Iran","volume":"22","author":"Bakht","year":"2022","journal-title":"BMC Microbiol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijregi.2023.01.002","article-title":"Epidemiology and mortality outcome of carbapenem-and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections","volume":"7","author":"Balkhair","year":"2023","journal-title":"IJID Regions"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2019.05.004","article-title":"Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend","volume":"85","author":"Balkhair","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/1120009X.2020.1793594","article-title":"Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms","volume":"32","author":"Bandic-Pavlovic","year":"2020","journal-title":"J. Chemother."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.ijmmb.2023.100494","article-title":"Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance","volume":"47","author":"Banerjee","year":"2024","journal-title":"Indian J. Med. Microbiol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/iwj.12519","article-title":"Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-beta-lactamase production","volume":"13","author":"Bangera","year":"2016","journal-title":"Int. Wound J."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: knowns and unknowns","volume":"48","author":"Baron","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref74","first-page":"112","article-title":"Epidemiological study of bacterial microbiology in AECOPD patients of Kolkata, India","volume":"6","author":"Basu","year":"2013","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7150\/ijms.4723","article-title":"Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey","volume":"10","author":"Bayram","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref76","first-page":"148","article-title":"Frequency of blaIMP and blaSPM metallo-\u03b2-lactamase genes among carbapenem-resistant pseudomonas aeruginosa clinical isolates in Sari, North of Iran","volume-title":"Recent Advances in Anti-Infective Drug Discovery Formerly Recent Patents on Anti-Infective Drug Discovery","author":"Bazgir","year":"2021"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bjid.2020.05.010","article-title":"Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: results from the study for monitoring antimicrobial resistance trends (SMART \u2013 Brazil; 2016-2017)","volume":"24","author":"Beirao","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13205-017-1019-8","article-title":"Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia","volume":"8","author":"Ben Nejma","year":"2018","journal-title":"3 Biotech"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.22207\/JPAM.14.3.43","article-title":"Non-fermenting gram negative Bacteria as Uropathogens in causing urinary tract infection and its antimicrobial susceptibility pattern at a tertiary Care Centre of South India","volume":"14","author":"Berwal","year":"2020","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","article-title":"Colistin, mechanisms and prevalence of resistance","volume":"31","author":"Bialvaei","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"785893","DOI":"10.3389\/fphar.2021.785893","article-title":"Pharmacokinetic\/pharmacodynamic based breakpoints of polymyxin B for bloodstream infections caused by multidrug-resistant gram-negative pathogens","volume":"12","author":"Bian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"14142","DOI":"10.1038\/s41598-023-40012-z","article-title":"A nested cohort 5-year Canadian surveillance of gram-negative antimicrobial resistance for optimized antimicrobial therapy","volume":"13","author":"Blondeau","year":"2023","journal-title":"Sci. Rep."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.3390\/ijms23169208","article-title":"Decoding genetic features and antimicrobial susceptibility of Pseudomonas aeruginosa strains isolated from bloodstream infections","volume":"23","author":"Bogiel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dialis.2015.02.006","article-title":"Prevalence of bacterial pathogens and their emerging resistance patterns in patients with renal diseases","volume":"36","author":"Bono","year":"2015","journal-title":"Di\u00e1lisis y Trasplante."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"105461","DOI":"10.1016\/j.micpath.2022.105461","article-title":"Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: a systematic review and meta-analysis","volume":"165","author":"Bonyadi","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13756-024-01376-7","article-title":"Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis","volume":"13","author":"Bostanghadiri","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.burns.2020.05.004","article-title":"Bacterial infection profile and predictors among patients admitted to a burn care center: a retrospective study","volume":"46","author":"Bourgi","year":"2020","journal-title":"Burns"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"136338","DOI":"10.5812\/archcid-136338","article-title":"Genetically diverse, extremely resistant, and Pan-drug resistant Pseudomonas aeruginosa as the Main cause of nosocomial infection among hospitalized patients","volume":"18","author":"Boustanshenas","year":"2023","journal-title":"Arch. Clin. Infect. Dis."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/biomedicines10123049","article-title":"Carbapenem-resistant gram-negative fermenting and non-fermenting rods isolated from hospital patients in Poland\u2014what are they susceptible to?","volume":"10","author":"Brauncajs","year":"2022","journal-title":"Biomedicines"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12879-020-05404-w","article-title":"Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland","volume":"20","author":"Brzozowski","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jinf.2019.12.006","article-title":"Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance","volume":"80","author":"Bunsow","year":"2020","journal-title":"J. Infect."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"354","DOI":"10.18683\/germs.2021.1272","article-title":"Antibiotic resistance of non-fermenting gram-negative bacilli isolated at a large infectious diseases Hospital in North-Eastern Romania, during an 11-year period","volume":"11","author":"Buzil\u0103","year":"2021","journal-title":"Germs"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1128\/AAC.01645-10","article-title":"Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study","volume":"55","author":"Cabot","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/pathogens12070918","article-title":"Genomics and antimicrobial susceptibility of clinical Pseudomonas aeruginosa isolates from hospitals in Brazil","volume":"12","author":"Camargo","year":"2023","journal-title":"Pathogens"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3399\/BJGPO.2022.0193","article-title":"Impact of the COVID-19 pandemic on antimicrobial stewardship support for general practices in England: a qualitative interview study","volume":"7","author":"Campbell","year":"2023","journal-title":"BJGP Open"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"447.e1","DOI":"10.1016\/j.cmi.2021.07.018","article-title":"In vitro activity of the novel siderophore cephalosporin, cefiderocol, in gram-negative pathogens in Europe by site of infection","volume":"28","author":"Candel","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1128\/AAC.01480-13","article-title":"In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ\/PhoP mgrB regulator","volume":"57","author":"Cannatelli","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"dlac030","DOI":"10.1093\/jacamr\/dlac030","article-title":"In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016\u201319)","volume":"4","author":"Canton","year":"2022","journal-title":"JAC-Antimicrobial Resistance"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"e02177","DOI":"10.1128\/AAC.02177-19","article-title":"Activity of Meropenem-Vaborbactam against bacterial isolates causing pneumonia in patients in U.S. hospitals during 2014 to 2018","volume":"64","author":"Carvalhaes","year":"2020","journal-title":"ASM J CD"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1128\/AAC.00313-18","article-title":"In vitro activity of plazomicin against gram-negative and gram-positive isolates collected from US hospitals and comparative activities of aminoglycosides against carbapenem-resistant Enterobacteriaceae and isolates carrying carbapenemase genes","volume":"62","author":"Castanheira","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/antibiotics11091268","article-title":"Homocysteine and inflammatory cytokines in the clinical assessment of infection in venous leg ulcers","volume":"11","author":"Cavallo","year":"2022","journal-title":"Antibiotics."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"687","DOI":"10.5336\/medsci.2011-24972","article-title":"Metallobeta-lactamase enzymes and antibiotic susceptibilities in strains of Pseudomonas Aeruginosa isolated from intensive care units in Turkey","volume":"32","author":"Cesur","year":"2012","journal-title":"Turkiye Klinikleri J Med Sci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5152\/B-ENT.2022.21425","article-title":"Treatment of multi-drug resistant microorganisms in chronic suppurative otitis media","volume":"18","author":"\u00c7etin","year":"2022","journal-title":"B-ENT"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.2147\/IDR.S421357","article-title":"Analysis on bacterial distribution and change of drug resistance rate in ICUs across Southwest China from 2018 to 2022","author":"Chang","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/0049475520977043","article-title":"Bloodstream infections and antibiotic sensitivity pattern in intensive care unit","volume":"51","author":"Chaturvedi","year":"2021","journal-title":"Trop. Dr."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"893","DOI":"10.31729\/jnma.5216","article-title":"Study of antibiotic susceptibility among bacterial isolates in neonatal intensive care unit of a tertiary care hospital: a descriptive cross-sectional study","volume":"58","author":"Chaudhary","year":"2020","journal-title":"JNMA J. Nepal Med. Assoc."},{"key":"ref109","doi-asserted-by":"crossref","DOI":"10.25258\/ijpqa.13.3.18","volume-title":"Colistin resistant gram-negative Bacteria isolated from various clinical samples in north Indian tertiary care center","author":"Chauhan","year":"2022"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/jcpt.12730","article-title":"The knowledge, attitude and practice of health practitioners towards antibiotic prescribing and resistance in developing countries\u2014a systematic review","volume":"43","author":"Chaw","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.2147\/IDR.S407515","article-title":"Ceftazidime\/avibactam for the treatment of carbapenem-resistant Pseudomonas aeruginosa infection in lung transplant recipients","volume":"16","author":"Chen","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"349","DOI":"10.33073\/pjm-2020-038","article-title":"Characterization of two macrolide resistance-related genes in multidrug-resistant Pseudomonas aeruginosa isolates","volume":"69","author":"Chen","year":"2020","journal-title":"Pol. J. Microbiol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/IDR.S368566","article-title":"Novel Pseudomonas aeruginosa strains co-Harbouring Bla (NDM-1) Metallo beta-lactamase and mcr-1 isolated from immunocompromised Paediatric patients","volume":"15","author":"Chen","year":"2022","journal-title":"Infect Drug Resist."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10096-014-2063-5","article-title":"Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China","volume":"33","author":"Chen","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"263","DOI":"10.7883\/yoken.JJID.2014.202","article-title":"In vitro analysis of activities of 16 antimicrobial agents against gram-negative bacteria from six teaching hospitals in China","volume":"68","author":"Chen","year":"2015","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3892\/etm.2020.8777","article-title":"Polymyxin B resistance rates in carbapenem-resistant Pseudomonas aeruginosa isolates and a comparison between Etest\u00ae and broth microdilution methods of antimicrobial susceptibility testing","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/jac\/dkz169","article-title":"Challenge of drug resistance in Pseudomonas aeruginosa: clonal spread of NDM-1-positive ST-308 within a tertiary hospital","volume":"74","author":"Chew","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/IDR.S67267","article-title":"Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a northern Thai tertiary-care university based general surgical intensive care unit","volume":"7","author":"Chittawatanarat","year":"2014","journal-title":"Infect. Drug Resist."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/jgid.jgid_110_18","article-title":"Global contributors to antibiotic resistance","volume":"11","author":"Chokshi","year":"2019","journal-title":"J. Global Infect. Dis."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/antibiotics12010165","article-title":"Antimicrobial susceptibility and molecular features of colonizing isolates of Pseudomonas aeruginosa and the report of a novel sequence type (ST) 3910 from Thailand","volume":"12","author":"Chukamnerd","year":"2023","journal-title":"Antibiotics"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.chest.2016.03.042","article-title":"Community-acquired pneumonia due to multidrug-and non\u2013multidrug-resistant Pseudomonas aeruginosa","volume":"150","author":"Cill\u00f3niz","year":"2016","journal-title":"Chest"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/mdr.2007.708","article-title":"Coexistence of epidemic colistin-only-sensitive clones of Pseudomonas aeruginosa, including the Bla SPM clone, spread in hospitals in a Brazilian Amazon city","volume":"13","author":"Cipriano","year":"2007","journal-title":"Microb. Drug Resist."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/IDR.S299742","article-title":"Screening of antimicrobial resistance genes and epidemiological features in hospital and community-associated carbapenem-resistant pseudomonas aeruginosa infections","volume":"14","author":"\u00c7opur \u00c7i\u00e7ek","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref124","first-page":"103","article-title":"Phenotypic and genotypic characteristics of Pseudomonas aeruginosa strains isolated from hospitals in the north-west region of Poland","volume":"55","author":"Czekaj\u0142o-Ko\u0142odziej","year":"2006","journal-title":"Pol. J. Microbiol."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"9852145","DOI":"10.1155\/2020\/9852145","article-title":"Synergistic effect between usnic acid and polymyxin B against resistant clinical isolates of Pseudomonas aeruginosa","volume":"2020","author":"da Costa J\u00fanior","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"417","DOI":"10.13005\/bbra\/1290","article-title":"Community acquired Pseudomonas aeroginosa urinary tract infections in children hospitalized in a Baqiatallah hospital, Tehran, Iran: virulence profile and antibiotic resistance properties","volume":"11","author":"Dadmanesh","year":"2014","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"911","DOI":"10.22207\/JPAM.17.2.18","article-title":"Central line associated blood stream infection: microbiological profile and its antimicrobial susceptibility pattern at tertiary care Centre","volume":"17","author":"Darji","year":"2023","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40121-016-0141-y","article-title":"In vitro activity of ceftolozane\/tazobactam alone or with an aminoglycoside against multi-drug-resistant Pseudomonas aeruginosa from pediatric cystic fibrosis patients","volume":"6","author":"Dassner","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"604555","DOI":"10.3389\/fmicb.2021.604555","article-title":"Phenotypic and genomic variability of serial Peri-Lung transplantation Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"12","author":"Datar","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref131","doi-asserted-by":"crossref","DOI":"10.4324\/9781003019480-7","volume-title":"Infectious disease threats: Antibiotic resistance, COVID-19, and future pandemics. Meeting the challenges of existential threats through educational innovation","author":"de Blasio","year":"2021"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcf.2015.09.004","article-title":"Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: results from a national multicenter study","volume":"15","author":"de Dios","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jiph.2012.11.006","article-title":"Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital","volume":"6","author":"De Francesco","year":"2013","journal-title":"J. Infect. Public Health"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.meegid.2019.05.015","article-title":"Epidemiology and antibiotic resistance trends in clinical isolates of Pseudomonas aeruginosa from Rio de janeiro-Brazil: importance of mutational mechanisms over the years (1995\u20132015)","volume":"73","author":"de Oliveira Santos","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1099\/jmm.0.056945-0","article-title":"Aetiology and antibiotic resistance patterns of urinary tract infections in the elderly: a 6-month study","volume":"62","author":"De Vecchi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"325","DOI":"10.24171\/j.phrp.2018.9.6.06","article-title":"Association between Beta-lactam antibiotic resistance and virulence factors in AmpC producing clinical strains of P. aeruginosa","volume":"9","author":"Dehbashi","year":"2018","journal-title":"Osong. Public Health Res. Perspect."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/AAC.01589-17","article-title":"Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain","volume":"61","author":"Del Barrio-Tofino","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"106196","DOI":"10.1016\/j.ijantimicag.2020.106196","article-title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update","volume":"56","author":"del Barrio-Tofi\u00f1o","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/antibiotics11020193","article-title":"XDR-Pseudomonas aeruginosa outside the ICU: is there still place for colistin?","volume":"11","author":"Del Giacomo","year":"2022","journal-title":"Antibiotics."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/jac\/dkaa117","article-title":"Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia","volume":"75","author":"Delgado-Valverde","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"99","DOI":"10.61186\/iem.9.2.99","article-title":"Molecular typing of multidrug-resistant Pseudomonas aeruginosa isolates obtained from hospitalized burn patients by rep-PCR","volume":"9","author":"Delroshan","year":"2023","journal-title":"Infect. Epidemiol. Microbiol."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"105905","DOI":"10.1016\/j.mimet.2020.105905","article-title":"Comparison of the recommended colistin susceptibility testing methods with colistin gradient strips and semi-automated method for antimicrobial-resistant non-fermenting rods","volume":"172","author":"Depka","year":"2020","journal-title":"J. Microbiol. Methods"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s10096-018-3287-6","article-title":"Evaluation of the accelerate Pheno\u2122 system for rapid identification and antimicrobial susceptibility testing of gram-negative bacteria in bloodstream infections","volume":"37","author":"Descours","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref144","article-title":"Microbiological profile and Antibiogram of Uropathogens isolated at a tertiary care hospital","volume":"10","author":"Dharati","year":"2021","journal-title":"J. Krishna Inst. Med. Sci."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/antibiotics10111402","article-title":"Epidemiology and pattern of resistance of gram-negative bacteria isolated from blood samples in hospitalized patients: a single center retrospective analysis from southern Italy","volume":"10","author":"Di Carlo","year":"2021","journal-title":"Antibiotics"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ijms18051077","article-title":"Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype","volume":"18","author":"Di Domenico","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1089\/mdr.2016.0219","article-title":"Epidemiological, physiological, and molecular characteristics of a Brazilian collection of Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"23","author":"Dias","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10096-018-3361-0","article-title":"Ceftolozane\/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands","volume":"37","author":"D\u00edaz-Ca\u00f1estro","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"00355","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.12669\/pjms.39.5.7188","article-title":"Co-existence of blaIMP, blaNDM-1, and blaSHV, genes of Pseudomonas aeruginosa isolated from Quetta: antimicrobial resistance and clinical significance","volume":"39","author":"Din","year":"2023","journal-title":"Pakistan J. Med. Sci."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"e30458","DOI":"10.1097\/MD.0000000000030458","article-title":"Community-acquired pneumonia-causing bacteria and antibiotic resistance rate among Vietnamese patients: a cross-sectional study","volume":"101","author":"Do Tran","year":"2022","journal-title":"Medicine"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/tcmj.tcmj_101_17","article-title":"Metallo-beta-lactamase-mediated resistance among clinical carbapenem-resistant Pseudomonas aeruginosa isolates in northern Iran: a potential threat to clinical therapeutics","volume":"30","author":"Dogonchi","year":"2018","journal-title":"Ci Ji Yi Xue Za Zhi."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jmii.2012.08.022","article-title":"Activities of doripenem against nosocomial bacteremic drug-resistant gram-negative bacteria in a medical center in Taiwan","volume":"45","author":"Dong","year":"2012","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"765113","DOI":"10.3389\/fmicb.2021.765113","article-title":"Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa clinical isolates from Saudi Arabia revealed a global dissemination of GES-5-producing ST235 and VIM-2-producing ST233 sub-lineages","volume":"12","author":"Doumith","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jgar.2018.04.015","article-title":"Temporal trends and patterns in antimicrobial-resistant gram-negative bacteria implicated in intensive care unit-acquired infections: a cohort-based surveillance study in Istanbul, Turkey","volume":"14","author":"Durdu","year":"2018","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"106718","DOI":"10.1016\/j.bioorg.2023.106718","article-title":"Mechanism and antibacterial synergies of poly(Dabco-BBAC) nanoparticles against multi-drug resistant Pseudomonas aeruginosa isolates from human burns","volume":"140","author":"Ebadati","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref157","first-page":"36","article-title":"Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care Centre in Western Turkey","volume":"22","author":"Ece","year":"2014","journal-title":"Infez. Med."},{"key":"ref158","article-title":"Genetic profiling of Pseudomonas aeruginosa isolates from Iranian patients with cystic fibrosis using RAPD-PCR and PFGE","volume-title":"Iranian Journal of Basic Medical Sciences","author":"Eftekhar","year":"2009"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.22207\/JPAM.14.3.28","article-title":"Battling biofilm forming nosocomial pathogens using chitosan and Pluronic F127","volume":"14","author":"Eid","year":"2020","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1007\/s11033-022-07930-z","article-title":"Molecular characterization and antibiogram of the carbapenemase gene variants in clinical strains of Pseudomonas aeruginosa","volume":"49","author":"Ejaz","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"01541","DOI":"10.1128\/AAC.01541-19","article-title":"Susceptibility of Pseudomonas aeruginosa recovered from cystic fibrosis patients to murepavadin and 13 comparator antibiotics","volume":"64","author":"Ekkelenkamp","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jiph.2019.08.012","article-title":"The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco","volume":"13","author":"El Mekes","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"105042","DOI":"10.1016\/j.micpath.2021.105042","article-title":"Antimicrobial resistance and virulence characteristics in ERIC-PCR typed biofilm forming isolates of P. aeruginosa","volume":"158","author":"Eladawy","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/IDR.S151783","article-title":"Ambulance vehicles as a source of multidrug-resistant infections: a multicenter study in Assiut City, Egypt","volume":"11","author":"El-Mokhtar","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"039","DOI":"10.1055\/s-0035-1557010","article-title":"Antimicrobial resistance of bacterial strains isolated from respiratory tract of cystic fibrosis patients with CFTR I1234V mutation","volume":"2","author":"Elshafie","year":"2007","journal-title":"J. Pediatr. Infect. Dis."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s10096-021-04288-1","article-title":"Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey","volume":"40","author":"El-Sokkary","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.genrep.2017.09.006","article-title":"Hospitalization length survey and relation with distribution of LasA protease and type III secretion system encoding-genes in multi-drug resistant Pseudomonas aeruginosa isolates from burn wounds in southwest of Iran","volume":"9","author":"Emami","year":"2017","journal-title":"Gene Rep."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"100377","DOI":"10.1016\/j.genrep.2019.100377","article-title":"Identification of different faces of Pseudomonas aeruginosa isolates in burn patients by genetic fingerprinting","volume":"15","author":"Emami","year":"2019","journal-title":"Gene Rep."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jbcr\/iraa007","article-title":"Evaluating the saliva of burn ICU patients for resistant Infections Harbor Metallo-beta-lactamase genes","volume":"41","author":"Emami","year":"2020","journal-title":"J. Burn Care Res."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5152\/eurasianjmed.2017.16262","article-title":"Evaluation of microorganisms causing ventilator-associated pneumonia in a pediatric intensive care unit","volume":"49","author":"Ergul","year":"","journal-title":"Eurasian J. Med."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5152\/TurkPediatriArs.2017.5451","article-title":"A retrospective evaluation of blood cultures in a pediatric intensive care unit: a three year evaluation","volume":"52","author":"Ergul","year":"","journal-title":"Turk Pediatri Ars."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s15010-018-1133-5","article-title":"Ceftolozane\/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections","volume":"46","author":"Escol\u00e0-Verg\u00e9","year":"2018","journal-title":"Infection"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/cid\/ciy801","article-title":"Rapid molecular diagnostics to Inform empiric use of ceftazidime\/avibactam and Ceftolozane\/Tazobactam against Pseudomonas aeruginosa: PRIMERS IV","volume":"68","author":"Evans","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09603123.2020.1726300","article-title":"Involvement of Pseudomonas aeruginosa in the occurrence of community and hospital acquired diarrhea, and its virulence diversity among the stool and the environmental samples","volume":"32","author":"Fakhkhari","year":"2022","journal-title":"Int. J. Environ. Health Res."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/jac\/dkx049","article-title":"Activity of cefiderocol (S-649266) against carbapenem-resistant gram-negative bacteria collected from inpatients in Greek hospitals","volume":"72","author":"Falagas","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"e04462","DOI":"10.1128\/spectrum.04462-22","article-title":"An XDR pseudomonas aeruginosa ST463 strain with an IncP-2 plasmid containing a novel transposon Tn 6485f encoding Bla IMP-45 and bla AFM-1 and a second plasmid with two copies of Bla KPC-2","volume":"11","author":"Fang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3855\/jidc.12012","article-title":"Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals","volume":"14","author":"Farag","year":"2020","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2147\/IDR.S198373","article-title":"Antimicrobial resistance pattern and molecular genetic distribution of metallo-\u03b2-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt","volume":"12","author":"Farhan","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1128\/AAC.01802-13","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. hospitals (2011-2012)","volume":"57","author":"Farrell","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/AAC.02465-14","article-title":"Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010","volume":"58","author":"Farrell","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijantimicag.2014.01.032","article-title":"Ceftolozane\/tazobactam activity tested against gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)","volume":"43","author":"Farrell","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3855\/jidc.2493","article-title":"Isolation and molecular characterization of New Delhi metallo-beta-lactamase-1 producing superbug in Bangladesh","volume":"7","author":"Farzana","year":"2013","journal-title":"J. Infect. Dev. Countries"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"117","DOI":"10.29252\/iem.6.2.117","article-title":"The study of frequency of SIM and AmpC genes in clinical isolates of Pseudomonas aeruginosa in Gilan, Iran","volume":"6","author":"Fekri Kohan","year":"2020","journal-title":"Infect. Epidemiol. Microbiol"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antibiotics8020062","article-title":"A 2-year single-Centre audit on antibiotic resistance of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae strains from an intensive care unit and other wards in a general public hospital in Greece","volume":"8","author":"Feretzakis","year":"2019","journal-title":"Antibiotics"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/antibiotics11070858","article-title":"Evaluation of three carbapenemase-phenotypic detection methods and emergence of diverse VIM and GES variants among Pseudomonas aeruginosa isolates in Tunisia","volume":"11","author":"Ferjani","year":"2022","journal-title":"Antibiotics"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1128\/JCM.00802-13","article-title":"Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients","volume":"51","author":"Fern\u00e1ndez-Olmos","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/jac\/dku025","article-title":"Ceftazidime\/avibactam activity tested against gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)","volume":"69","author":"Flamm","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3947\/ic.2021.0015","article-title":"Evolution of antimicrobial resistance levels of ESKAPE microorganisms in a Peruvian IV-level hospital","volume":"53","author":"Flores-Paredes","year":"2021","journal-title":"Infect Chemother."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1046\/j.1469-0691.2001.00247.x","article-title":"Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients","volume":"7","author":"Fluge","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/milmed\/usab259","article-title":"Clinical characteristics and resistance patterns of Pseudomonas aeruginosa isolated from combat casualties","volume":"187","author":"Ford","year":"2022","journal-title":"Mil. Med."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/AAC.01117-20","article-title":"Mechanisms of resistance to Ceftolozane\/Tazobactam in Pseudomonas aeruginosa: results of the GERPA multicenter study","volume":"65","author":"Fournier","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/jac\/dkt098","article-title":"Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa","volume":"68","author":"Fournier","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/microorganisms11040974","article-title":"The first Swedish outbreak with VIM-2-producing Pseudomonas aeruginosa, occurring between 2006 and 2007, was probably due to contaminated hospital sinks","volume":"11","author":"Fraenkel","year":"2023","journal-title":"Microorganisms"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1590\/S1807-59322010000900002","article-title":"Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital","volume":"65","author":"Franco","year":"2010","journal-title":"Clinics"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s42770-022-00888-x","article-title":"Genotypic characterization and clonal relatedness of metallo-\u03b2-lactamase-producing non-fermentative gram negative bacteria in the first 5 years of their circulation in Paraguay (2011-2015)","volume":"54","author":"Franco","year":"2023","journal-title":"Braz. J. Microbiol."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22207\/JPAM.14.1.13","article-title":"Propolis extract: a possible antiseptic Oral care against multidrug-resistant non-fermenting Bacteria isolated from non-ventilator hospital-acquired pneumonia","volume":"14","author":"Gaber","year":"2020","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/ijmy.ijmy_61_21","article-title":"A cross-sectional study of etiological and sensitivity profiling of meningitis in under-five children","volume":"10","author":"Gahlot","year":"2021","journal-title":"Int J Mycobacteriol."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/antibiotics10091134","article-title":"No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study","volume":"10","author":"Gajd\u00e1cs","year":"","journal-title":"Antibiotics (Basel)"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/antibiotics8030143","article-title":"Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot","volume":"8","author":"Gajd\u00e1cs","year":"2019","journal-title":"Antibiotics"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"105","DOI":"10.14232\/abs.2021.1.105-112","article-title":"Insights on carbapenem-resistant Pseudomonas aeruginosa","volume":"65","author":"Gajd\u00e1cs","year":"","journal-title":"Acta Biologica Szegediensis."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ijantimicag.2008.01.011","article-title":"Colistin susceptibility testing by Etest and disk diffusion methods","volume":"31","author":"Galani","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1093\/jac\/dkaa160","article-title":"In vitro activity of ceftolozane\/tazobactam alone and in combination with amikacin against MDR\/XDR Pseudomonas aeruginosa isolates from Greece","volume":"75","author":"Galani","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref203","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2012.04.007","article-title":"Antimicrobial resistance among gram-negative bacilli isolated from Latin America: results from SENTRY antimicrobial surveillance program (Latin America, 2008\u20132010)","volume":"73","author":"Gales","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref204","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of gram-negative pathogens: results from the SENTRY antimicrobial surveillance program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-\u03b2-lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref206","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/microorganisms11081996","article-title":"Detection of plasmid-mediated resistance against Colistin in multi-drug-resistant gram-negative Bacilli isolated from a tertiary hospital","volume":"11","author":"Galindo-Mendez","year":"2023","journal-title":"Microorganisms"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/indianjotol.indianjotol_8_21","article-title":"Clinical implications of culture and sensitivity data in chronic otitis media","volume":"27","author":"Gangwar","year":"2021","journal-title":"Indian J. Otol."},{"key":"ref208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2021.07.014","article-title":"In vitro activity of cefiderocol and comparators against gram-negative bacterial isolates from a series of surveillance studies in England: 2014\u20132018","volume":"27","author":"Gant","year":"2021","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref209","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1128\/JCM.00753-11","article-title":"Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals","volume":"49","author":"Garc\u00eda-Castillo","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref210","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijantimicag.2019.02.004","article-title":"Activity of ceftolozane\/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: the SUPERIOR multicentre study","volume":"53","author":"Garcia-Fernandez","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/ijmr.IJMR_36_18","article-title":"Molecular epidemiology & therapeutic options of carbapenem-resistant gram-negative bacteria","volume":"149","author":"Garg","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-01756-0","article-title":"Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria","volume":"20","author":"Gaudereto","year":"2020","journal-title":"BMC Microbiol."},{"key":"ref213","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21608\/bfsa.2023.301132","article-title":"Association between antibiotic resistance, biofilm formation and LASB gene in Pseudomonas Aeruginosa isolated from different clinical specimens","volume":"46","author":"Ghanem","year":"2023","journal-title":"Bull. Pharm. Sci. Assiut Univ."},{"key":"ref214","doi-asserted-by":"publisher","first-page":"e24850","DOI":"10.1002\/jcla.24850","article-title":"Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection","volume":"37","author":"Ghasemian","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"key":"ref215","doi-asserted-by":"publisher","first-page":"134","DOI":"10.30699\/ijmm.16.2.134","article-title":"A six-month survey of the frequency of extensively drug-resistant gram-negative bacteria by VITEK 2 system in 2020","volume":"16","author":"Ghasemshahi","year":"2022","journal-title":"Iranian J. Med. Microbiol."},{"key":"ref216","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.diagmicrobio.2019.01.012","article-title":"Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"94","author":"Gherardi","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref217","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jac\/dkx453","article-title":"Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane\/tazobactam and comparators, and molecular epidemiology of carbapenemase producers","volume":"73","author":"Giani","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref219","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2015\/JCPSP.726729","article-title":"In vitro efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-test","volume":"25","author":"Gilani","year":"2015","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref220","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3103\/S0891416817020057","article-title":"Prevalence and molecular characterization of class 1 integrons among clinical isolates of Pseudomonas aeruginosa in northwest of Iran","volume":"32","author":"Goli","year":"2017","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"ref221","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.meegid.2016.08.022","article-title":"Contribution of mexAB-oprM and mexXY (\u2212oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran","volume":"45","author":"Goli","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref222","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.2147\/IDR.S383285","article-title":"Prevalence of multidrug-resistant pathogens causing bloodstream infections in an intensive care unit","volume":"15","author":"Golli","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref223","doi-asserted-by":"publisher","first-page":"1113969","DOI":"10.3389\/fmolb.2023.1113969","article-title":"Super-infection by multiple microorganisms in COVID-19 patients","volume":"10","author":"Gomez","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"ref224","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1179\/joc.2009.21.3.267","article-title":"Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs","volume":"21","author":"G\u00f3mez-Garc\u00e9s","year":"2009","journal-title":"J. Chemother."},{"key":"ref225","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2180-13-138","article-title":"Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain","volume":"13","author":"Gomila","year":"2013","journal-title":"BMC Microbiol."},{"key":"ref226","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/ijp.ijp_1013_20","article-title":"Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: a cross sectional analytical study","volume":"53","author":"Gunalan","year":"2021","journal-title":"Indian J. Pharmacol."},{"key":"ref227","doi-asserted-by":"publisher","first-page":"e16162","DOI":"10.7717\/peerj.16162","article-title":"Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis","volume":"11","author":"Guo","year":"2023","journal-title":"PeerJ."},{"key":"ref228","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00284-022-03048-4","article-title":"High rates of extensively drug-resistant Pseudomonas aeruginosa in children with cystic fibrosis","volume":"79","author":"Gutierrez-Santana","year":"2022","journal-title":"Curr. Microbiol."},{"key":"ref229","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/5584_2016_163","article-title":"Bacteriological assessment of pneumonia caused by gram-negative Bacteria in patients hospitalized in intensive care unit","volume":"955","author":"Guzek","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref230","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2014_23","article-title":"Etiological factors causing lower respiratory tract infections isolated from hospitalized patients","volume":"835","author":"Guzek","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref231","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000119741","article-title":"In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients","volume":"54","author":"G\u00fczel","year":"2008","journal-title":"Chemotherapy"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"e01968","DOI":"10.1128\/AAC.01968-17","article-title":"In Vitro activity of the Siderophore cephalosporin, Cefiderocol, against Carbapenem-nonsusceptible and multidrug-resistant isolates of gram-negative Bacilli collected worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref233","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jiph.2022.08.020","article-title":"Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: a multicenter retrospective study","volume":"15","author":"Hakeam","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"126","DOI":"10.12816\/0060171","article-title":"Lebanese Observatory of Pathogenic Agents (Lopa-study): a 2 year-surveillance prospective study","volume":"68","author":"Hallit","year":"2020","journal-title":"Lebanese Med. J."},{"key":"ref235","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jcf.2008.06.009","article-title":"Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience","volume":"7","author":"Hansen","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref236","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3390\/microorganisms11102542","article-title":"Distribution and drug resistance of bacterial infection in hospitalized patients at the respiratory department before and after the COVID-19 pandemic in Guangzhou, China","volume":"11","author":"Hao","year":"2023","journal-title":"Microorganisms"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"30085","DOI":"10.2807\/1560-7917.ES.2015.20.49.30085","article-title":"Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015","volume":"20","author":"Hasman","year":"2015","journal-title":"Eur. Secur."},{"key":"ref238","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/lam.13818","article-title":"Molecular mechanisms and clonal lineages of colistin-resistant bacteria across the African continent: a scoping review","volume":"75","author":"Hassen","year":"2022","journal-title":"Lett. Appl. Microbiol."},{"key":"ref239","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jgar.2021.07.012","article-title":"Surveillance of ceftobiprole against gram-positive and gram-negative clinical isolates from 2018 from different European territories","volume":"26","author":"Hawser","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref240","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s11033-022-07225-3","article-title":"Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran","volume":"49","author":"Heidari","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref241","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.pathol.2018.08.009","article-title":"Activity of ceftolozane\/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia","volume":"50","author":"Henderson","year":"2018","journal-title":"Pathology"},{"key":"ref242","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/antibiotics9120885","article-title":"In vitro activity of pentamidine alone and in combination with antibiotics against multidrug-resistant clinical Pseudomonas aeruginosa strains","volume":"9","author":"Herrera-Espejo","year":"2020","journal-title":"Antibiotics"},{"key":"ref243","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1128\/JCM.03385-12","article-title":"Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant gram-negative bacilli","volume":"51","author":"Hindler","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref244","doi-asserted-by":"publisher","first-page":"e0207134","DOI":"10.1371\/journal.pone.0207134","article-title":"Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235","volume":"13","author":"Hishinuma","year":"2018","journal-title":"PLoS One"},{"key":"ref245","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jgar.2020.09.010","article-title":"Emergence and spread of VIM-type metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan","volume":"23","author":"Hishinuma","year":"2020","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref246","doi-asserted-by":"publisher","first-page":"e0057823","DOI":"10.1128\/aac.00578-23","article-title":"Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models","volume":"67","author":"Holger","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref247","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/jam.15647","article-title":"Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: in vitro synergy testing","volume":"133","author":"Holger","year":"","journal-title":"J. Appl. Microbiol."},{"key":"ref248","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s40121-022-00687-9","article-title":"Impact of ceftolozane\u2013tazobactam vs. best alternative therapy on clinical outcomes in patients with multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa lower respiratory tract infections","volume":"11","author":"Holger","year":"","journal-title":"Infect. Dis. Ther."},{"key":"ref249","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3947\/ic.2015.47.1.33","article-title":"Characteristics of Metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in Korea","volume":"47","author":"Hong","year":"2015","journal-title":"Infect. Chemother."},{"key":"ref250","doi-asserted-by":"publisher","first-page":"355","DOI":"10.26650\/IUITFD.1092556","article-title":"In vitro activity of ceftazidime-avibactam and colistin against carbapenem-resistant Pseudomonas aeruginosa clinical isolates","volume":"85","author":"Ho\u015fbul","year":"2022","journal-title":"J. Istanbul Faculty Med."},{"key":"ref251","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/abr.abr_239_16","article-title":"Distribution of the strains of multidrug-resistant, extensively drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa isolates from burn patients","volume":"6","author":"Hosseininassab Nodoushan","year":"2017","journal-title":"Adv. Biomed. Res."},{"key":"ref252","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/jac\/dkab461","article-title":"Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study","volume":"77","author":"Howard-Anderson","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref253","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/antibiotics9090630","article-title":"Current antibiotic resistance trends of uropathogens in Central Europe: survey from a tertiary hospital urology department 2011\u20132019","volume":"9","author":"Hrbacek","year":"2020","journal-title":"Antibiotics"},{"key":"ref254","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jac\/dky425","article-title":"In vitro activities of cefiderocol, ceftolozane\/tazobactam, ceftazidime\/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan","volume":"74","author":"Hsueh","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref255","doi-asserted-by":"publisher","first-page":"001656","DOI":"10.1099\/jmm.0.001656","article-title":"Antimicrobial susceptibility study and molecular epidemiology of ceftazidime\/avibactam against Pseudomonas aeruginosa collected from clinical patients in PR China (2004\u20132021)","volume":"72","author":"Hu","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"ref256","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/mSystems.00154-21","article-title":"Emergence and expansion of a Carbapenem-resistant Pseudomonas aeruginosa clone are associated with plasmid-borne Bla (KPC-2) and virulence-related genes","volume":"6","author":"Hu","year":"","journal-title":"mSystems"},{"key":"ref257","doi-asserted-by":"publisher","first-page":"670202","DOI":"10.3389\/fmicb.2021.670202","article-title":"A potential high-risk clone of Pseudomonas aeruginosa ST463","volume":"12","author":"Hu","year":"","journal-title":"Front. Microbiol."},{"key":"ref258","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/antibiotics11101392","article-title":"Evaluation of agar dilution method in susceptibility testing of Polymyxins for Enterobacteriaceae and non-fermentative rods: advantages compared to broth microdilution and broth macrodilution","volume":"11","author":"Hu","year":"2022","journal-title":"Antibiotics"},{"key":"ref259","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jmii.2022.05.003","article-title":"Metal nanoparticles and nanoparticle composites are effective against Haemophilus influenzae, Streptococcus pneumoniae, and multidrug-resistant bacteria","volume":"55","author":"Huang","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref260","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1128\/AAC.03056-15","article-title":"In vitro activity of ceftazidime-avibactam against contemporary Pseudomonas aeruginosa isolates from U.S. medical centers by census region, 2014","volume":"60","author":"Huband","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref261","doi-asserted-by":"publisher","first-page":"115191","DOI":"10.1016\/j.diagmicrobio.2020.115191","article-title":"In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017\u20132018)","volume":"98","author":"Huband","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref262","doi-asserted-by":"publisher","first-page":"106724","DOI":"10.1016\/j.ijantimicag.2023.106724","article-title":"Multidrug-resistant gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018\u20132020","volume":"61","author":"Humphries","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref263","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.15537\/smj.2018.10.22944","article-title":"High antimicrobial resistant rates among gram-negative pathogens in intensive care units. A retrospective study at a tertiary care hospital in Southwest Saudi Arabia","volume":"39","author":"Ibrahim","year":"2018","journal-title":"Saudi Med. J."},{"key":"ref264","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","article-title":"Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals","volume":"48","author":"Ibrahim","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref265","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/antibiotics12040670","article-title":"Pseudomonas bacteremia in a tertiary hospital and factors associated with mortality","volume":"12","author":"Ioannou","year":"2023","journal-title":"Antibiotics"},{"key":"ref266","first-page":"98","article-title":"First detection of New Delhi metallo-\u03b2-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals","volume":"10","author":"Ismail","year":"2018","journal-title":"Iran. J. Microbiol."},{"key":"ref267","doi-asserted-by":"publisher","first-page":"57341","DOI":"10.5812\/jjm.57341","article-title":"Occurrence of a multidrug resistant Pseudomonas aeruginosa strains in hospitalized patients in southwest of Iran: characterization of resistance trends and virulence determinants","volume":"11","author":"Izadi Pour Jahromi","year":"2018","journal-title":"J. Microbiol."},{"key":"ref268","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4149\/10.4149\/BLL_2021_063","article-title":"Isolated carbapenem resistant bacteria, their multidrug resistant profile, percentage of healthcare associated infection and associated mortality, in hospitalized patients in a University Hospital in Bratislava","volume":"122","author":"Jalali","year":"2021","journal-title":"Clin. Study"},{"key":"ref269","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40199-018-0234-0","article-title":"Down-regulatory effects of green coffee extract on las I and las R virulence-associated genes in Pseudomonas aeruginosa","volume":"27","author":"Jamalifar","year":"2019","journal-title":"DARU J. Pharm. Sci."},{"key":"ref270","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/emph\/eow016","article-title":"Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung","volume":"2016","author":"Jansen","year":"2016","journal-title":"Evol. Med. Public Health"},{"key":"ref271","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3855\/jidc.1212","article-title":"Ventilator-associated pneumonia in Iranian intensive care units","volume":"5","author":"Japoni","year":"2011","journal-title":"J. Infect. Dev. Countries"},{"key":"ref272","doi-asserted-by":"publisher","first-page":"30","DOI":"10.31782\/IJCRR.2020.12127","article-title":"Bacteriological and antimicrobial sensitivity profile of burn wound infections in a tertiary Care Hospital of Uttarakhand","volume":"12","author":"Jauhari","year":"2020","journal-title":"Int. J. Curr. Res. Rev."},{"key":"ref273","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.26452\/ijrps.v11i4.3592","article-title":"Microbiological profile and drug resistant Organism's pattern in diabetic foot ulcer patients at tertiary care hospital Puducherry","volume":"11","author":"Jayarani","year":"2020","journal-title":"Int. J. Res. Pharmaceutical Sci."},{"key":"ref274","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.5897\/AJMR11.1023","article-title":"Phenotypic detection of metallo-\u03b2-lactamase producing Pseudomonas aeruginosa isolated from Urmia hospitals","volume":"6","author":"Jazani","year":"2012","journal-title":"African J. Microbiol. Res."},{"key":"ref275","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijantimicag.2008.08.026","article-title":"Nationwide surveillance of antimicrobial resistance among non-fermentative gram-negative bacteria in intensive care units in Taiwan: SMART programme data 2005","volume":"33","author":"Jean","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref276","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jmii.2021.07.015","article-title":"Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018","volume":"55","author":"Jean","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref277","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jmii.2014.12.008","article-title":"Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART)","volume":"49","author":"Jean","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref278","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3343\/alm.2024.44.1.38","article-title":"Changing genotypic distribution, antimicrobial susceptibilities, and risk factors of urinary tract infection caused by carbapenemase-producing pseudomonas aeruginosa","volume":"44","author":"Jeong","year":"2024","journal-title":"Ann. Lab. Med."},{"key":"ref279","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1099\/jmm.0.000742","article-title":"Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives","volume":"67","author":"Jimenez-Guerra","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref280","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diagmicrobio.2013.07.003","article-title":"Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011)","volume":"77","author":"Jones","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref281","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.diagmicrobio.2013.10.008","article-title":"Resistance surveillance program report for selected European nations (2011)","volume":"78","author":"Jones","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref282","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","article-title":"Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)","volume":"17","author":"Jones","year":"","journal-title":"Braz. J. Infect. Dis."},{"key":"ref283","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jgar.2017.08.002","article-title":"Colistin resistance among blood culture isolates at a tertiary care Centre in Hungary","volume":"11","author":"Juh\u00e1sz","year":"","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref284","doi-asserted-by":"publisher","first-page":"14034","DOI":"10.5812\/jjm.14034","article-title":"In vitro activity of Colistin and trimethoprim\/sulfamethoxazole against consortia of multidrug resistant non-fermenting gram-negative Bacilli isolated from lower respiratory tract","volume":"10","author":"Juh\u00e1sz","year":"","journal-title":"Jundishapur J. Microbiol."},{"key":"ref285","doi-asserted-by":"publisher","first-page":"8781","DOI":"10.1038\/s41598-019-44965-y","article-title":"Differences in Colistin administration and bacterial and treatment outcomes in critically ill patients","volume":"9","author":"Jung","year":"2019","journal-title":"Sci. Rep."},{"key":"ref286","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/ijms24021519","article-title":"Dissemination of metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in Serbian hospital settings: expansion of ST235 and ST654 clones","volume":"24","author":"Kabic","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref287","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.22207\/JPAM.14.2.32","article-title":"Antibiogram of gram negative bacteria isolated from the skin and soft tissue infections a guide for empirical therapy to the clinicians","volume":"14","author":"Kakhandki","year":"2020","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref288","doi-asserted-by":"publisher","first-page":"115904","DOI":"10.1016\/j.diagmicrobio.2023.115904","article-title":"Comparative in vitro antipseudomonal activity of ceftolozane\/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis","volume":"105","author":"Kanwar","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref289","doi-asserted-by":"publisher","first-page":"100561","DOI":"10.1016\/j.genrep.2019.100561","article-title":"The correlation between biofilm formation capability and antibiotic resistance pattern in Pseudomonas aeruginosa","volume":"18","author":"Karami","year":"2020","journal-title":"Gene Rep."},{"key":"ref290","doi-asserted-by":"publisher","first-page":"210","DOI":"10.15171\/jnp.2017.35","article-title":"Evaluating the resistance pattern of gram-negative bacteria during three years at the nephrology ward of a referral hospital in southwest of Iran","volume":"6","author":"Karimzadeh","year":"2017","journal-title":"J. Nephropathol."},{"key":"ref291","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1128\/AAC.01485-13","article-title":"In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study","volume":"57","author":"Karlowsky","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref292","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jgar.2022.04.011","article-title":"Antimicrobial susceptibility testing of clinical isolates of gram-negative bacilli collected in Morocco by the ATLAS global surveillance program from 2018 to 2020","volume":"30","author":"Karlowsky","year":"2022","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref293","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijantimicag.2018.11.007","article-title":"In vitro activity of cefiderocol, a siderophore cephalosporin, against gram-negative bacilli isolated by clinical laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015","volume":"53","author":"Karlowsky","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref294","doi-asserted-by":"publisher","first-page":"e01814","DOI":"10.1128\/AAC.01814-18","article-title":"In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa collected in Latin American countries: results from the INFORM global surveillance program, 2012 to 2015","volume":"63","author":"Karlowsky","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref295","doi-asserted-by":"publisher","first-page":"dlad098","DOI":"10.1093\/jacamr\/dlad098","article-title":"Activity of ceftolozane\/tazobactam and imipenem\/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)\u2014SMART 2017\u201321","volume":"5","author":"Karlowsky","year":"2023","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref296","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.00169-18","article-title":"In vitro activity of imipenem-Relebactam against clinical isolates of gram-negative Bacilli isolated in Hospital Laboratories in the United States as part of the SMART 2016 program","volume":"62","author":"Karlowsky","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref297","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jgar.2018.07.012","article-title":"Activity of imipenem\/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015\u20132016","volume":"15","author":"Karlowsky","year":"","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref298","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/jpids\/piaa056","article-title":"In vitro activity of imipenem\/Relebactam against gram-negative Bacilli from pediatric patients-study for monitoring antimicrobial resistance trends (SMART) global surveillance program 2015-2017","volume":"10","author":"Karlowsky","year":"2021","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"ref299","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/antibiotics11101411","article-title":"Clinical characteristics and outcome of MDR\/XDR bacterial infections in a neuromuscular semi-intensive\/sub-intensive care unit","volume":"11","author":"Karruli","year":"2022","journal-title":"Antibiotics"},{"key":"ref300","doi-asserted-by":"publisher","first-page":"40896","DOI":"10.5812\/archcid.40896","article-title":"The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients","volume":"12","author":"Kashfi","year":"2017","journal-title":"Arch. Clin. Infect. Dis."},{"key":"ref301","doi-asserted-by":"publisher","first-page":"e0195757","DOI":"10.1371\/journal.pone.0195757","article-title":"Carbapenem-resistant gram-negative pathogens in a German university medical center: prevalence, clinical implications and the role of novel beta-lactam\/beta-lactamase inhibitor combinations","volume":"13","author":"Katchanov","year":"2018","journal-title":"PLoS One"},{"key":"ref302","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4103\/1995-7645.351764","article-title":"Assessment of colistin resistance in gram negative bacteria from clinical samples in resource-limited settings","volume":"15","author":"Kaur","year":"2022","journal-title":"Asian Pac J Trop Med"},{"key":"ref303","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1093\/jac\/dky267","article-title":"In vitro activity of ceftazidime\/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15","volume":"73","author":"Kazmierczak","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref304","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1128\/AAC.02379-15","article-title":"Multiyear, multinational survey of the incidence and global distribution of Metallo-\u03b2-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"60","author":"Kazmierczak","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref305","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/HIV.S229531","article-title":"Opportunistic respiratory infections in HIV patients attending sukraraj tropical and infectious diseases hospital in Kathmandu, Nepal","volume":"11","author":"Kc","year":"2019","journal-title":"HIV\/AIDS Res. Palliative Care"},{"key":"ref306","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1128\/AAC.02894-14","article-title":"Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against \u03b2-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"58","author":"Keepers","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref307","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.7860\/JCDR\/2013\/5509.3137","article-title":"Emergence of NDM\u20131 in the clinical isolates of Pseudomonas aeruginosa in India","volume":"7","author":"Khajuria","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"ref308","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2975610","article-title":"Acute bacterial meningitis in Qatar: a hospital-based study from 2009 to 2013","volume":"2017","author":"Khan","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref309","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3855\/jidc.18142","article-title":"Increased burden of MDR bacterial infections; reflection from an antibiogram of ICUs of a tertiary care hospital","volume":"17","author":"Khan","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref310","first-page":"1320","article-title":"Detection of carbapenem-resistant Pseudomonas aeruginosa in tertiary care hospital in Saudi Arabia","author":"Khater","year":"2022","journal-title":"Microbes Infect. Dis."},{"key":"ref311","doi-asserted-by":"publisher","first-page":"693","DOI":"10.21608\/mid.2022.142569.1320","article-title":"Detection of carbapenem-resistant Pseudomonas aeruginosa in tertiary care hospital in Saudi Arabia","volume":"3","author":"Khater","year":"2022","journal-title":"Microbes Infect. Dis."},{"key":"ref312","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/2277-9175.219412","article-title":"Pseudomonas aeruginosa-producing Metallo-beta-lactamases (VIM, IMP, SME, and AIM) in the clinical isolates of intensive care units, a University Hospital in Isfahan","volume":"6","author":"Khorvash","year":"2017","journal-title":"Iran. Adv. Biomed. Res."},{"key":"ref313","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/2221-6189.254426","article-title":"Distribution of extended-spectrum \u03b2-lactamase genes in antibiotic-resistant strains of Pseudomonas aeruginosa obtained from burn patients in Ahvaz, Iran","volume":"8","author":"Khoshnood","year":"2019","journal-title":"J. Acute Dis."},{"key":"ref314","doi-asserted-by":"publisher","first-page":"e0183061","DOI":"10.1371\/journal.pone.0183061","article-title":"The frequency of class1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran","volume":"12","author":"Khosravi","year":"2017","journal-title":"PLoS One"},{"key":"ref315","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.burns.2016.02.012","article-title":"The frequency of genes encoding exotoxin a and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients","volume":"42","author":"Khosravi","year":"2016","journal-title":"Burns"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.24996\/ijs.2021.62.1.7","article-title":"Detection of the antiseptic resistance gene among Pseudomonas aeruginosa isolates","volume":"62","author":"Khudair","year":"2021","journal-title":"Iraqi J. Sci."},{"key":"ref316","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1128\/JCM.00014-09","article-title":"Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients","volume":"47","author":"Kidd","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref317","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"ref318","doi-asserted-by":"publisher","first-page":"799084","DOI":"10.3389\/fmicb.2021.799084","article-title":"Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017\u20132019: phase i report from kor-glass","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref319","doi-asserted-by":"publisher","first-page":"v20i3","DOI":"10.4314\/thrb.v20i3.6","article-title":"Antimicrobial susceptibility pattern and multidrug resistance \u0131ndex in Pseudomonas aeruginosa among clinical isolates in Denizli, Turkey","volume":"20","author":"K\u0131rac","year":"2018","journal-title":"Tanzan. J. Health Res."},{"key":"ref320","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jgar.2021.08.010","article-title":"In vitro activity of ceftazidime\/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018","volume":"27","author":"Kiratisin","year":"2021","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref321","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jgar.2023.06.005","article-title":"Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017-2020","volume":"34","author":"Kiratisin","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref322","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-020-00355-1","article-title":"In vitro activity of ceftazidime\u2013avibactam and comparators against gram-negative bacterial isolates collected in the Asia\u2013Pacific region as part of the INFORM program (2015\u20132017)","volume":"19","author":"Ko","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref323","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jgar.2022.11.017","article-title":"In vitro antibacterial activities of cefiderocol against gram-negative clinical strains isolated from China in 2020","volume":"32","author":"Kohira","year":"2023","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref324","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3855\/jidc.9725","article-title":"Bacterial profile and antibiogram of blood stream infections in febrile neutropenic patients with haematological malignancies","volume":"12","author":"Kokkayil","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref325","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.4103\/jfmpc.jfmpc_2480_20","article-title":"Clinico-bacteriological and antibiotic drug resistance profile of chronic suppurative otitis media at a tertiary care hospital in Western Rajasthan","volume":"10","author":"Kombade","year":"2021","journal-title":"J. Family Med. Prim. Care"},{"key":"ref326","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/ijms23010284","article-title":"Benefits of usage of immobilized silver nanoparticles as Pseudomonas aeruginosa antibiofilm factors","volume":"23","author":"Korzekwa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref327","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40001-022-00752-6","article-title":"Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration","volume":"27","author":"Kothari","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref328","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1089\/mdr.2018.0458","article-title":"Microorganisms profile and antibiotics sensitivity patterns in the only medical intensive care unit in Bosnia and Herzegovina","volume":"25","author":"Kovacevic","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"ref329","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/jac\/dkaa543","article-title":"Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening","volume":"76","author":"Kragh","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref330","doi-asserted-by":"publisher","first-page":"00977","DOI":"10.1128\/AAC.00977-19","article-title":"Potent LpxC inhibitors with in vitro activity against multidrug-resistant Pseudomonas aeruginosa","volume":"63","author":"Krause","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref331","doi-asserted-by":"publisher","first-page":"105959","DOI":"10.1016\/j.ijantimicag.2020.105959","article-title":"Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany","volume":"55","author":"Kresken","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref332","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.ijantimicag.2020.106128","article-title":"In vitro activity of cefiderocol against aerobic gram-negative bacterial pathogens from Germany","volume":"56","author":"Kresken","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref333","doi-asserted-by":"publisher","first-page":"115420","DOI":"10.1016\/j.diagmicrobio.2021.115420","article-title":"In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014\u20132017 and 2018","volume":"101","author":"Kristof","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref334","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1093\/jac\/dkab141","article-title":"In vitro activity of imipenem\/relebactam, meropenem\/vaborbactam, ceftazidime\/avibactam, cefepime\/zidebactam and other novel antibiotics against imipenem-non-susceptible gram-negative bacilli from Taiwan","volume":"76","author":"Kuo","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref335","doi-asserted-by":"publisher","first-page":"e02235","DOI":"10.1128\/spectrum.02235-21","article-title":"In vitro antibacterial activity of imipenem\/relebactam against clinical isolates in Japan","volume":"10","author":"Kurihara","year":"2022","journal-title":"Microbiol. Spectrum."},{"key":"ref336","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/IDR.S194482","article-title":"Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from surveillance of multicenter antimicrobial resistance in Taiwan (SMART)","volume":"12","author":"Lai","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref337","first-page":"2004","article-title":"Resistance features of pseudomonas aeruginosa strains isolated from patients with infectious complications of cardiovascular surgery","volume":"7","author":"Laurentiu","year":"2017","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref338","first-page":"580","article-title":"In vitro activities of nine current antibiotics against culprit bacteria in nosocomial infections in an institution in northern Taiwan","volume":"34","author":"Lee","year":"2011","journal-title":"Chang Gung Med. J."},{"key":"ref339","doi-asserted-by":"publisher","first-page":"106867","DOI":"10.1016\/j.ijantimicag.2023.106867","article-title":"In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: data from the antimicrobial testing leadership and surveillance (ATLAS) program, 2012-2021","volume":"62","author":"Lee","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref340","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2011.11.014","article-title":"Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient","volume":"72","author":"Lee","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref341","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijantimicag.2019.06.009","article-title":"Nationwide surveillance of antimicrobial resistance among clinically important gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART) in 2018","volume":"54","author":"Lee","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref342","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/mdr.2010.0145","article-title":"Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea","volume":"17","author":"Lee","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"ref343","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.2147\/IDR.S408956","article-title":"The distribution, drug susceptibility, and dynamic trends of Pseudomonas aeruginosa infection in a tertiary Hospital in China during 2016\u20132022","volume":"16","author":"Li","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref344","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/jcpt.13446","article-title":"Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital","volume":"46","author":"Li","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref345","article-title":"Interaction of biofilm and efflux pump in clinical isolates of carbapenem resistant P. aeruginosa","volume":"26","author":"Li","year":"2022","journal-title":"European Rev. Med. Pharmacol. Sci."},{"key":"ref346","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/antibiotics10010010","article-title":"Antimicrobial resistance in pathogens isolated from blood cultures: a two-year multicenter hospital surveillance study in Italy","volume":"10","author":"Licata","year":"2020","journal-title":"Antibiotics"},{"key":"ref347","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jmii.2014.01.005","article-title":"Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: prevalence, risk factors, and impact on outcome of infections","volume":"49","author":"Lin","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref348","doi-asserted-by":"publisher","first-page":"00556","DOI":"10.1128\/AAC.00556-19","article-title":"Resistance and heteroresistance to colistin in Pseudomonas aeruginosa isolates from Wenzhou, China","volume":"63","author":"Lin","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref349","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1039\/C8AN02220H","article-title":"Rapid screening of colistin-resistant Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa by the use of Raman spectroscopy and hierarchical cluster analysis","volume":"144","author":"Lin","year":"2019","journal-title":"Analyst"},{"key":"ref350","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1128\/AAC.01089-20","article-title":"National surveillance of antimicrobial susceptibility of Bacteremic gram-negative Bacteria with emphasis on community-acquired resistant isolates: report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)","volume":"64","author":"Liu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref351","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/IDR.S163853","article-title":"Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study","volume":"11","author":"Liu","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref352","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref353","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/jac\/dkx136","article-title":"Activity of ceftolozane\/tazobactam against surveillance and \u2018problem\u2019Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles","volume":"72","author":"Livermore","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref354","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jac\/dkt115","article-title":"Diversity of \u03b2-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study","volume":"68","author":"Llanes","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref355","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10096-023-04549-1","article-title":"Activity of ceftolozane\/tazobactam and imipenem\/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland\u2014SMART 2017\u20132020","volume":"42","author":"Lob","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref356","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/AAC.4.3.281","article-title":"Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials","volume":"4","author":"Lockwood","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref357","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jacamr\/dlaa060","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible gram-negative bacteria from Europe","volume":"2","author":"Longshaw","year":"2020","journal-title":"JAC Antimicrob. Resist."},{"key":"ref358","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40121-021-00570-z","article-title":"Aminoglycoside or Polymyxin monotherapy for treating complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa: a propensity score-adjusted and matched cohort study","volume":"11","author":"L\u00f3pez Montesinos","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref359","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2017.03.034","article-title":"Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-Centre study","volume":"50","author":"Lopez-Causape","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref360","doi-asserted-by":"publisher","first-page":"e71001","DOI":"10.1371\/journal.pone.0071001","article-title":"Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection","volume":"8","author":"Lopez-Causape","year":"2013","journal-title":"PLoS One"},{"key":"ref361","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/jac\/dku567","article-title":"Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance","volume":"70","author":"Ly","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref362","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.19193\/0393-6384_2017_6_163","article-title":"Phenotypic and genotypic virulence factors in Pseudomonas aeruginosa strains according to pigment presence","volume":"33","author":"Macin","year":"2017","journal-title":"Acta Medica Mediterranea."},{"key":"ref363","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcf.2004.03.009","article-title":"Antibiograms of resistant gram-negative bacteria from Scottish CF patients","volume":"3","author":"MacKenzie","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref364","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.12669\/pjms.36.6.2138","article-title":"Emerging anti-microbial resistance in febrile neutropenia: is it high time to evaluate quality control measures?","volume":"36","author":"Mahar","year":"2020","journal-title":"Pak J Med Sci."},{"key":"ref365","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.22092\/ARI.2022.359032.2357","article-title":"Isolation and characterization of bacteriophages active against Pseudomonas aeruginosa strains isolated from diabetic foot infections","volume":"77","author":"Mahdy","year":"2022","journal-title":"Archives of Razi Institute."},{"key":"ref366","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.21608\/mid.2021.53173.1096","article-title":"Effect of Meropenem-Colistin and Meropenem-amikacin combinations against Carbapenem-resistant Pseudomonas aeruginosa isolates in Suez Canal university hospitals","author":"Mahmoud","year":"2021","journal-title":"Microbes and Infectious Diseases."},{"key":"ref367","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1128\/JCM.43.9.4480-4485.2005","article-title":"Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips","volume":"43","author":"MaI","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref368","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12941-023-00636-5","article-title":"Multidrug-resistant gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study","volume":"22","author":"Maina","year":"2023","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref369","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.2147\/IDR.S276975","article-title":"Antibiogram and genetic characterization of Carbapenem-resistant gram-negative pathogens incriminated in healthcare-associated infections","volume":"13","author":"Makharita","year":"2020","journal-title":"Infect Drug Resist."},{"key":"ref370","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13104-019-4344-7","article-title":"In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran","volume":"12","author":"Malekzadegan","year":"2019","journal-title":"BMC. Res. Notes"},{"key":"ref371","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jtumed.2022.10.012","article-title":"Phenotypic and genotypic characterization of clinical Pseudomonas aeruginosa","volume":"18","author":"Mallikarjuna","year":"2023","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref372","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijantimicag.2004.11.009","article-title":"Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis Centre","volume":"25","author":"Manno","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref373","doi-asserted-by":"publisher","first-page":"71","DOI":"10.26719\/2013.19.1.71","article-title":"Epidemiological characterization of P. aeruginosa isolates of intensive care units in Egypt and Saudi Arabia","volume":"19","author":"Mansour","year":"2013","journal-title":"East Mediterr. Health J."},{"key":"ref374","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000437252","article-title":"Susceptibility of 2,252 Pseudomonas aeruginosa clinical isolates over 4 years to 9 antimicrobials in a tertiary Greek hospital","volume":"60","author":"Maraki","year":"2015","journal-title":"Chemotherapy"},{"key":"ref375","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/sur.2011.115","article-title":"Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wards","volume":"13","author":"Maraki","year":"2012","journal-title":"Surg. Infect."},{"key":"ref376","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7546\/CRABS.2021.06.12","article-title":"High level of colistin resistant gram-negative bacteria in a university hospital in Bulgaria","volume":"74","author":"Marteva-Proevska","year":"2021","journal-title":"Comptes Rendus de L Academie Bulgare des Sci."},{"key":"ref377","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1128\/AAC.05758-11","article-title":"Two novel class I integron arrays containing IMP-18 metallo-\u03b2-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico","volume":"56","author":"Mart\u00ednez","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref378","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/23744235.2020.1767803","article-title":"Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa","volume":"52","author":"Mataraci Kara","year":"2020","journal-title":"Infect Dis."},{"key":"ref379","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin \u2013 evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp","volume":"24","author":"Matuschek","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref380","doi-asserted-by":"publisher","first-page":"iv32","DOI":"10.1093\/jac\/dkz285","article-title":"Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007\u201316 study","volume":"74","author":"McCracken","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref381","doi-asserted-by":"publisher","first-page":"26","DOI":"10.37757\/MR2013V15.N2.6","article-title":"Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance","volume":"15","author":"Medell","year":"2013","journal-title":"MEDICC Rev."},{"key":"ref382","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bjid.2012.08.005","article-title":"Clinical and microbiological characterization of pneumonia in mechanically ventilated patients","volume":"16","author":"Medell","year":"2012","journal-title":"Braz. J. Infect. Dis."},{"key":"ref383","first-page":"269","article-title":"Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients","volume":"99","author":"Mellouli","year":"2021","journal-title":"La Tunisie Medicale"},{"key":"ref384","article-title":"Colistin, an option for treatment of multiple drug resistant Pseudomonas aeruginosa","volume-title":"Physiol Pharmacol.","author":"Memar","year":"2016"},{"key":"ref385","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/AAC.01121-13","article-title":"Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)","volume":"57","author":"Mendes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref386","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.burns.2016.02.023","article-title":"Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria","volume":"42","author":"Meradji","year":"2016","journal-title":"Burns"},{"key":"ref387","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13756-015-0067-2","article-title":"Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in eastern Algeria","volume":"4","author":"Meradji","year":"2015","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref388","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/antibiotics10101224","article-title":"Combined resistance to Ceftolozane-Tazobactam and ceftazidime-avibactam in extensively drug-resistant (XDR) and multidrug-resistant (MDR) Pseudomonas aeruginosa: resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs","volume":"10","author":"Meschiari","year":"2021","journal-title":"Antibiotics"},{"key":"ref389","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/biom9110662","article-title":"One-step synthesis of Silver nanoparticles using Saudi Arabian Desert seasonal plant Sisymbrium irio and antibacterial activity against multidrug-resistant bacterial strains","volume":"9","author":"Mickymaray","year":"2019","journal-title":"Biomol. Ther."},{"key":"ref390","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10096-015-2529-0","article-title":"Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania","volume":"35","author":"Mikucionyte","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref391","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ppul.24535","article-title":"Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections","volume":"55","author":"Milczewska","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref392","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2478\/aiht-2020-71-3418","article-title":"Phenotypic and genetic properties of susceptible and multidrug-resistant Pseudomonas aeruginosa isolates in southern Serbia","volume":"71","author":"Milojkovi\u0107","year":"2020","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"ref393","first-page":"72","article-title":"Study on imipenem resistance and prevalence of blaVIM1 and blaVIM2 metallo-beta lactamases among clinical isolates of Pseudomonas aeruginosa from Mashhad, northeast of Iran","volume":"7","author":"Mirbagheri","year":"2015","journal-title":"Iran J. Microbiol."},{"key":"ref394","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.4103\/jfmpc.jfmpc_1430_20","article-title":"Study of microbiological and antibiotic sensitivity pattern of ventilator associated pneumonia (VAP) in ICU of a tertiary care hospital in Nepal","volume":"9","author":"Mishra","year":"2020","journal-title":"J. Family Med. Prim. Care"},{"key":"ref395","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1051\/bmdcn\/2018080102","article-title":"Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from northwest of Iran","volume":"8","author":"Mobaraki","year":"2018","journal-title":"Biomedicine"},{"key":"ref396","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/antibiotics10060622","article-title":"Epidemiological characteristics and predisposing factors for surgical site infections caused by bacterial pathogens exhibiting multidrug-resistant patterns","volume":"10","author":"Mohamed","year":"2021","journal-title":"Antibiotics"},{"key":"ref397","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/tropicalmed7030042","article-title":"Antimicrobial resistance and predisposing factors associated with catheter-associated UTI caused by uropathogens exhibiting multidrug-resistant patterns: a 3-year retrospective study at a tertiary hospital in Mogadishu, Somalia","volume":"7","author":"Mohamed","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"ref398","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/mdr.2010.0195","article-title":"In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt","volume":"17","author":"Mohamed","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"ref399","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2147\/IDR.S248043","article-title":"Global sequence analysis and expression of Azurin gene in different clinical specimens of burn patients with Pseudomonas aeruginosa infection","volume":"13","author":"Mohammadi Barzelighi","year":"2020","journal-title":"Infect Drug Resist."},{"key":"ref400","doi-asserted-by":"publisher","DOI":"10.5812\/pedinfect.41267","article-title":"Evaluation of the virulence features and antibiotic resistance patterns of pathogenic Pseudomonas aeruginosa strains isolated from hospitalized patients in Gonabad, Iran","author":"Mohammadzadeh","year":"2017","journal-title":"Arch. Pediatric Infect. Dis."},{"key":"ref401","doi-asserted-by":"publisher","first-page":"103946","DOI":"10.1016\/j.micpath.2019.103946","article-title":"Inhibitory effects of Cinnamaldehyde, Carvacrol, and honey on the expression of exoS and ampC genes in multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infections","volume":"140","author":"Mohammadzamani","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref402","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3855\/jidc.2924","article-title":"Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp","volume":"7","author":"Mohanty","year":"2013","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref403","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"ref404","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.2147\/IDR.S409726","article-title":"Antimicrobial resistance pattern of Pseudomonas aeruginosa: An 11-year experience in a tertiary care hospital in Makkah, Saudi Arabia","volume":"16","author":"Momenah","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref405","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jac\/dkx483","article-title":"Antibacterial activity of ceftolozane\/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa","volume":"73","author":"Monogue","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref406","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jgar.2019.04.012","article-title":"Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones","volume":"18","author":"Montero","year":"2019","journal-title":"J Glob Antimicrob Resist."},{"key":"ref407","doi-asserted-by":"publisher","first-page":"e02542","DOI":"10.1128\/AAC.02542-19","article-title":"Efficacy of Ceftolozane-Tazobactam in combination with Colistin against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones, in an in vitro Pharmacodynamic model","volume":"64","author":"Montero","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref408","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/jcm9020514","article-title":"Risk factors for mortality among patients with Pseudomonas aeruginosa bloodstream infections: what is the influence of XDR phenotype on outcomes?","volume":"9","author":"Montero","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref409","doi-asserted-by":"publisher","first-page":"769","DOI":"10.18502\/ijm.v13i6.8078","article-title":"Frequency and antimicrobial resistance pattern of bacterial isolates from patients with COVID-19 in two hospitals of Zanjan","volume":"13","author":"Moradi","year":"2021","journal-title":"Iranian J. Microbiol."},{"key":"ref410","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1128\/AAC.00750-12","article-title":"Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia","volume":"56","author":"Morata","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref411","article-title":"Susceptibility of common urinary isolates to the commonly used antibiotics in a tertiary hospital in southern Nigeria","volume":"5","author":"Mordi","year":"2006","journal-title":"Afr. J. Biotechnol."},{"key":"ref412","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.diagmicrobio.2012.12.012","article-title":"Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program","volume":"75","author":"Morrow","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref413","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1080\/10717544.2019.1693708","article-title":"Synthesis and evaluation of polymeric micelle containing piperacillin\/tazobactam for enhanced antibacterial activity","volume":"26","author":"Morteza","year":"2019","journal-title":"Drug Deliv."},{"key":"ref414","doi-asserted-by":"publisher","first-page":"75","DOI":"10.18683\/germs.2022.1308","article-title":"Febrile illness of bacterial etiology in a public fever hospital in Egypt: high burden of multidrug resistance and WHO priority gram negative pathogens","volume":"12","author":"Mostafa","year":"2022","journal-title":"Germs"},{"key":"ref415","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijid.2019.04.027","article-title":"Role of outer membrane permeability, efflux mechanism, and carbapenemases in carbapenem-nonsusceptible Pseudomonas aeruginosa from Dubai hospitals: results of the first cross-sectional survey","volume":"84","author":"Moubareck","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref416","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.eimc.2020.05.022","article-title":"Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study","volume":"39","author":"Mulet","year":"2021","journal-title":"Enferm Infect. Microbiol. Clin."},{"key":"ref417","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence","volume":"3","author":"Munn","year":"2014","journal-title":"Int. J. Health Policy Manag."},{"key":"ref418","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1128\/AAC.01046-16","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients in northern Europe","volume":"60","author":"Mustafa","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref419","doi-asserted-by":"publisher","first-page":"dlab081","DOI":"10.1093\/jacamr\/dlab081","article-title":"In vitro activity of cefiderocol and comparators against isolates of gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in France","volume":"3","author":"Naas","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"ref420","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/jac\/dkz505","article-title":"In vitro effects of combined iron chelation, antibiotics and matrix disruption on clinical isolates of Pseudomonas aeruginosa","volume":"75","author":"Nair","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref421","first-page":"383","article-title":"Virulence genes and antibiotic resistance profile of Pseudomonas aeruginosa isolates in northwest of Iran","volume":"9","author":"Najafi","year":"2015","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref422","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12941-022-00520-8","article-title":"Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis","volume":"21","author":"Narimisa","year":"2022","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref423","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2298\/VSP131224108S","article-title":"Pseudomonas aeruginosa serotypes and resistance to antibiotics from wound swabs","volume":"72","author":"Nedeljkovi\u0107","year":"2015","journal-title":"Vojnosanit. Pregl."},{"key":"ref424","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jiph.2023.05.032","article-title":"Analysis of cumulative antibiogram reports in intensive care units at an Egyptian university hospital","volume":"16","author":"Negm","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref425","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43168-021-00059-w","article-title":"Antibiograms of intensive care units at an Egyptian tertiary care hospital","volume":"15","author":"Negm","year":"2021","journal-title":"Egyptian J. Bronchol."},{"key":"ref426","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/AAC.46.3.940-940.2002","article-title":"Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations","volume":"46","author":"Nelson","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref427","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/antibiotics10050595","article-title":"Colistin dosing regimens against Pseudomonas aeruginosa in critically ill patients: An application of Monte Carlo simulation","volume":"10","author":"Nguyen","year":"2021","journal-title":"Antibiotics"},{"key":"ref428","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref429","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/medicina59061143","article-title":"Etiology and multi-drug resistant profile of bacterial infections in severe burn patients, Romania 2018-2022","volume":"59","author":"Nitescu","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"ref430","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/microorganisms9040786","article-title":"Molecular detection of drug-resistance genes of Bla OXA-23-Bla OXA-51 and mcr-1 in clinical isolates of Pseudomonas aeruginosa","volume":"9","author":"Nitz","year":"2021","journal-title":"Microorganisms"},{"key":"ref431","article-title":"In vitro antimicrobial activity of Cinnamomum verum, Allium sativum, and Zingiber officinale extracts on metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa: A potential therapeutic approach","volume-title":"Acta Microbiologica Hellenica","author":"Nojookambari","year":"2019"},{"key":"ref432","doi-asserted-by":"publisher","first-page":"115204","DOI":"10.1016\/j.diagmicrobio.2020.115204","article-title":"In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis","volume":"99","author":"Nolan","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref433","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4314\/eamj.v79i4.8879","article-title":"Pathogenic agents of chronic suppurative otitis media in Ilorin, Nigeria","volume":"79","author":"Nwabuisi","year":"2002","journal-title":"East African Med. J."},{"key":"ref434","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1183\/09031936.04.00122903","article-title":"Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units","volume":"24","author":"O'Carroll","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref435","first-page":"5","article-title":"Multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria hospitals","volume":"3","author":"Odumosu","year":"2012","journal-title":"Blood"},{"key":"ref436","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.genrep.2020.100877","article-title":"Emergence of VIM metallo-\u03b2-lactamase among carbapenem-resistant Pseudomonas species in Northwest Nigeria","volume":"21","author":"Olowo-okere","year":"2020","journal-title":"Gene Rep."},{"key":"ref437","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.burns.2013.11.003","article-title":"Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance","volume":"40","author":"\u00d6nc\u00fcl","year":"2014","journal-title":"Burns"},{"key":"ref438","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref439","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5578\/mb.68066","article-title":"Evaluation of the BD phoenix100 system and colistin broth disk elution method for antimicrobial susceptibility testing of colistin against gram-negative bacteria","volume":"53","author":"\u00d6zhak","year":"2019","journal-title":"Mikrobiyoloji Bulteni"},{"key":"ref440","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2016.02.017","article-title":"Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?","volume":"85","author":"Ozsurekci","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref441","first-page":"1714","article-title":"Antimicrobial resistance problems in a university hospital","volume":"97","author":"Ozumba","year":"2005","journal-title":"J. Natl. Med. Assoc."},{"key":"ref442","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis."},{"key":"ref443","doi-asserted-by":"publisher","first-page":"e01329","DOI":"10.1128\/JCM.01329-17","article-title":"Multicenter evaluation of the accelerate PhenoTest BC kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis","volume":"56","author":"Pancholi","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref444","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref445","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/antibiotics11081114","article-title":"Effects of levofloxacin, Aztreonam, and Colistin on enzyme synthesis by P. aeruginosa isolated from cystic fibrosis patients","volume":"11","author":"Pani","year":"2022","journal-title":"Antibiotics"},{"key":"ref446","doi-asserted-by":"publisher","first-page":"01811","DOI":"10.1128\/AAC.01811-17","article-title":"Molecular characterization of carbapenemase-producing Pseudomonas aeruginosa of Czech origin and evidence for clonal spread of extensively resistant sequence type 357 expressing IMP-7 metallo-\u03b2-lactamase","volume":"61","author":"Papagiannitsis","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref447","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.2147\/IDR.S338827","article-title":"New beta-lactam antibiotics and Ceragenins \u2013 a study to assess their potential in treatment of infections caused by multidrug-resistant strains of Pseudomonas aeruginosa","volume":"14","author":"Paprocka","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref448","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.anl.2016.07.005","article-title":"Difference of type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media","volume":"44","author":"Park","year":"2017","journal-title":"Auris Nasus Larynx"},{"key":"ref449","doi-asserted-by":"publisher","first-page":"e05041","DOI":"10.1016\/j.heliyon.2020.e05041","article-title":"Molecular characterization of polymorphisms among Pseudomonas aeruginosa strains isolated from burn patients' wounds","volume":"6","author":"Parsa","year":"2020","journal-title":"Heliyon."},{"key":"ref450","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/mdr.2011.0019","article-title":"Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates","volume":"18","author":"Pasca","year":"2012","journal-title":"Microb. Drug Resist."},{"key":"ref451","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1473-3099(15)00463-6","article-title":"Colistin resistance: a major breach in our last line of defence","volume":"16","author":"Paterson","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref452","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.mimet.2009.07.008","article-title":"Identification of pathogenic bacteria in blood cultures: comparison between conventional and PCR methods","volume":"78","author":"Pechorsky","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"ref453","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s10096-012-1629-3","article-title":"Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients","volume":"31","author":"Pe\u00f1a","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref454","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/jac\/dkz030","article-title":"High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial","volume":"74","author":"P\u00e9rez","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref455","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1128\/AAC.02372-14","article-title":"Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio","volume":"58","author":"Perez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref456","doi-asserted-by":"publisher","first-page":"106026","DOI":"10.1016\/j.ijantimicag.2020.106026","article-title":"Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2","volume":"56","author":"P\u00e9rez-V\u00e1zquez","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref457","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/antibiotics12030453","article-title":"In vitro activity of ceftolozane-tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa obtained from blood cultures from sentinel public hospitals in South Africa","volume":"12","author":"Perovic","year":"2023","journal-title":"Antibiotics."},{"key":"ref458","doi-asserted-by":"publisher","first-page":"741","DOI":"10.31925\/farmacia.2021.4.15","article-title":"Bacterial pathogens isolated from surgical site infections and their antibiotic susceptibility","volume":"69","author":"Petca","year":"2021","journal-title":"Farmacia"},{"key":"ref459","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3855\/jidc.7658","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria","volume":"10","author":"Petrova","year":"2016","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref460","first-page":"302","article-title":"Dissemination of Pseudomonas aeruginosa producing blaIMP-1 and blaVIM-1 in Qazvin and Alborz educational hospitals, Iran","volume":"7","author":"Peymani","year":"2015","journal-title":"Iran J. Microbiol."},{"key":"ref461","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2017.02.020","article-title":"Antimicrobial activity of tigecycline and cefoperazone\/sulbactam tested against 18,386 gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)","volume":"88","author":"Pfaller","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref462","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.2147\/IDR.S387097","article-title":"Ceftolozane\/tazobactam activity against drug-resistant Pseudomonas aeruginosa and enterobacterales causing healthcare-associated infections in eight Asian countries: report from an antimicrobial surveillance program (2016\u20132018)","volume":"15","author":"Pfaller","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref463","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijantimicag.2017.09.016","article-title":"Ceftolozane\/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an antimicrobial surveillance Programme (2013-2015)","volume":"51","author":"Pfaller","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref464","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/AAC.00453-09","article-title":"Diversity of \u03b2-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil","volume":"53","author":"Pic\u00e3o Renata","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref465","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12879-021-06153-0","article-title":"In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018)","volume":"21","author":"Pierard","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref466","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/thorax.58.9.794","article-title":"Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents","volume":"58","author":"Pitt","year":"2003","journal-title":"Thorax"},{"key":"ref467","first-page":"249","article-title":"Evaluation of efflux pumps gene expression in resistant Pseudomonas aeruginosa isolates in an Iranian referral hospital","volume":"8","author":"Pourakbari","year":"2016","journal-title":"Iran J Microbiol."},{"key":"ref468","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/ijmm.IJMM_17_349","article-title":"In silico and in vitro activity of ceftolozane\/tazobactam against pseudomonas aeruginosa collected across Indian hospitals","volume":"36","author":"Pragsam","year":"2018","journal-title":"Indian J. Med. Microbiol."},{"key":"ref469","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1099\/jmm.0.000508","article-title":"The distribution of carbapenem-and colistin-resistance in gram-negative bacteria from the Tamil Nadu region in India","volume":"66","author":"Prasanth Manohar","year":"2017","journal-title":"J Med Microbiol"},{"key":"ref470","doi-asserted-by":"publisher","first-page":"37002","DOI":"10.7759\/cureus.37002","article-title":"Feasibility of using ceftazidime-avibactam as a therapeutic option for bloodstream infections caused by multidrug-resistant Enterobacterales and Pseudomonas aeruginosa based on its susceptibility profile","volume":"15","author":"Priyadarshi","year":"2023","journal-title":"Cureus"},{"key":"ref471","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/jbcr\/irz096","article-title":"The bacteriological profile of burn wound infections at a tertiary Burns Center in Nepal","volume":"40","author":"Pujji","year":"2019","journal-title":"J. Burn Care Res."},{"key":"ref472","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.7759\/cureus.809","article-title":"Antibiogram of medical intensive care unit at tertiary care hospital setting of Pakistan","volume":"8","author":"Qadeer","year":"2016","journal-title":"Cureus"},{"key":"ref473","doi-asserted-by":"publisher","first-page":"e33664","DOI":"10.5812\/atr.33664","article-title":"Emerging Carbapenem-resistant Pseudomonas aeruginosa isolates carrying Bla(IMP) among burn patients in Isfahan, Iran","volume":"5","author":"Radan","year":"2016","journal-title":"Arch Trauma Res."},{"key":"ref474","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jgar.2019.09.008","article-title":"Distribution and antibiotic resistance profile of key gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: RESOURCE multicentre surveillance 2017 study","volume":"21","author":"Rafalskiy","year":"2020","journal-title":"J Glob Antimicrob Resist."},{"key":"ref475","doi-asserted-by":"publisher","first-page":"115977","DOI":"10.5812\/jjm.115977","article-title":"Molecular detection of carbapenemases and extended-spectrum \u03b2-lactamases-encoding genes in clinical isolates of pseudomonas aeruginosa in Iran","volume":"14","author":"Rahimi","year":"2021","journal-title":"Jundishapur J. Microbiol."},{"key":"ref476","doi-asserted-by":"publisher","first-page":"e103253","DOI":"10.1371\/journal.pone.0103253","article-title":"Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study","volume":"9","author":"Rajenderan","year":"2014","journal-title":"PLoS One"},{"key":"ref477","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2147\/IDR.S170233","article-title":"Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations","volume":"11","author":"Ramadan","year":"2018","journal-title":"Infect Drug Resist."},{"key":"ref478","doi-asserted-by":"publisher","first-page":"e0182524","DOI":"10.1371\/journal.pone.0182524","article-title":"Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa","volume":"12","author":"Ramanathan","year":"2017","journal-title":"PLoS One"},{"key":"ref479","first-page":"812","article-title":"Frequency and antimicrobial susceptibility pattern of Pseudomonas aeruginosa in ear swabs","volume":"30","author":"Rashid","year":"2014","journal-title":"World Appl. Sci. J."},{"key":"ref480","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2334-13-167","article-title":"Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria","volume":"13","author":"Rattanaumpawan","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref481","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1099\/jmm.0.001072","article-title":"Emerging multidrug resistance isolates of hospital-acquired bacterial meningitis in a tertiary care Centre in North India","volume":"68","author":"Raza","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref482","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/0019-509X.175363","article-title":"Review of spectrum and sensitivity of bacterial bloodstream isolates in children with malignancy: a retrospective analysis from a single center","volume":"51","author":"Reddy","year":"2014","journal-title":"Indian J. Cancer"},{"key":"ref483","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12941-014-0043-3","article-title":"Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance","volume":"13","author":"Rizek","year":"2014","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref484","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1590\/s1678-9946201961020","article-title":"Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital","volume":"61","author":"Rodulfo","year":"2019","journal-title":"Rev. Inst. Med. Trop."},{"key":"ref485","doi-asserted-by":"publisher","first-page":"01955","DOI":"10.1128\/AAC.01955-19","article-title":"Activity of cefiderocol and comparators against isolates from cancer patients","volume":"64","author":"Rolston","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref486","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/INF.0000000000002714","article-title":"Pseudomonas aeruginosa isolates from a cohort of Mexican children with cystic fibrosis show adaptation to a chronic phenotype","volume":"39","author":"Rosales-Reyes","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref487","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1128\/AAC.00707-08","article-title":"First countrywide survey of acquired metallo-\u03b2-lactamases in gram-negative pathogens in Italy","volume":"52","author":"Rossolini","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref488","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1099\/acmi.0.000595.v3","article-title":"Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant gram-negative Bacilli","volume":"5","author":"Rout","year":"2023","journal-title":"Access Microbiol."},{"key":"ref489","doi-asserted-by":"publisher","first-page":"150175","DOI":"10.1098\/rsob.150175","article-title":"Genomic islands 1 and 2 play key roles in the evolution of extensively drug-resistant ST235 isolates of Pseudomonas aeruginosa","volume":"6","author":"Roy Chowdhury","year":"2016","journal-title":"Open Biol."},{"key":"ref490","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12879-022-07678-8","article-title":"Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017\u20132018)","volume":"22","author":"Ruekit","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"ref491","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5505\/TurkHijyen.2016.82653","article-title":"Antibiotic resistance rates of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae isolated from a university-affiliated hospital in North Cyprus","volume":"73","author":"Ruh","year":"2016","journal-title":"Turk Hij Den Biyol Derg."},{"key":"ref492","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8060178","article-title":"Pseudomonas aeruginosa isolates from Spanish children: occurrence in Faecal samples, antimicrobial resistance, virulence, and molecular typing","volume":"2018","author":"Ruiz-Roldan","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref493","first-page":"271","article-title":"Identification of plasmid OXA and other \u03b2-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the clinical university hospital in northeastern Poland","volume":"38","author":"Sacha","year":"2015","journal-title":"New Microbiol."},{"key":"ref494","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1093\/jac\/dkaa278","article-title":"Susceptibility trends of ceftolozane\/tazobactam and comparators when tested against European gram-negative bacterial surveillance isolates collected during 2012-18","volume":"75","author":"Sader","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref495","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijid.2019.11.006","article-title":"Antimicrobial activity of cefoperazone-sulbactam tested against gram-negative organisms from Europe, Asia-Pacific, and Latin America","volume":"91","author":"Sader","year":"","journal-title":"Int. J. Infect. Dis."},{"key":"ref496","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/jac\/dkz074","article-title":"Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY antimicrobial surveillance program (1997-2016)","volume":"74","author":"Sader","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref497","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2018.04.012","article-title":"Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the international network for optimal resistance monitoring (INFORM) surveillance program, 2015-2016","volume":"92","author":"Sader","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref498","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.diagmicrobio.2015.06.008","article-title":"Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from unites states medical centers (2011-2014)","volume":"83","author":"Sader","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref499","doi-asserted-by":"publisher","first-page":"e02083","DOI":"10.1128\/AAC.02083-16","article-title":"Antimicrobial activity of ceftazidime-avibactam against gram-negative Bacteria isolated from patients hospitalized with pneumonia in U.S. medical centers, 2011 to 2015","volume":"61","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref500","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1128\/AAC.00405-16","article-title":"Antimicrobial activities of ceftazidime-avibactam and comparator agents against gram-negative organisms isolated from patients with urinary tract infections in U.S. medical centers, 2012 to 2014","volume":"60","author":"Sader","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref501","doi-asserted-by":"publisher","first-page":"e00072","DOI":"10.1128\/AAC.00072-17","article-title":"WCK 5222 (Cefepime-Zidebactam) antimicrobial activity against clinical isolates of gram-negative Bacteria collected worldwide in 2015","volume":"61","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref502","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.diagmicrobio.2016.11.019","article-title":"Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014)","volume":"87","author":"Sader","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref503","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/jac\/dky279","article-title":"Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)","volume":"73","author":"Sader","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref504","doi-asserted-by":"publisher","first-page":"e01045","DOI":"10.1128\/AAC.01045-17","article-title":"Antimicrobial activity of ceftazidime-avibactam tested against multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa isolates from U.S. medical centers, 2013 to 2016","volume":"61","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref505","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab126","article-title":"Antimicrobial activity of ceftazidime\/avibactam, ceftolozane\/tazobactam and comparator agents against Pseudomonas aeruginosa from cystic fibrosis patients","volume":"3","author":"Sader","year":"","journal-title":"JAC Antimicrob. Resist."},{"key":"ref506","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/jac\/dku184","article-title":"Antimicrobial activity of ceftolozane\/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)","volume":"69","author":"Sader","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref507","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)","volume":"78","author":"Sader","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref508","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2014.04.004","article-title":"Ceftolozane\/tazobactam activity tested against aerobic gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)","volume":"69","author":"Sader","year":"","journal-title":"J. Infect."},{"key":"ref509","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.01587-18","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa to ceftazidime-avibactam, Ceftolozane-Tazobactam, piperacillin-Tazobactam, and Meropenem stratified by U.S. Census divisions: results from the 2017 INFORM program","volume":"62","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref510","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/jac\/dky227","article-title":"Murepavadin activity tested against contemporary (2016-17) clinical isolates of XDR Pseudomonas aeruginosa","volume":"73","author":"Sader","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref511","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy210.841","volume-title":"1004. Frequency of occurrence and antimicrobial susceptibility of Bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015\u20132017). Open forum infectious diseases","author":"Sader","year":""},{"key":"ref512","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/AAC.02252-16","article-title":"Pseudomonas aeruginosa antimicrobial susceptibility results from four years (2012 to 2015) of the international network for optimal resistance monitoring program in the United States","volume":"61","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref513","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1128\/AAC.04839-14","article-title":"Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia","volume":"59","author":"Sader","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref514","doi-asserted-by":"publisher","first-page":"dlab117","DOI":"10.1093\/jacamr\/dlab117","article-title":"Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY antimicrobial surveillance program (2016\u201319)","volume":"3","author":"Sader","year":"","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref515","first-page":"265","article-title":"aeruginosa isolated from patients in Tehran, Iran","volume":"10","author":"Saderi","year":"2015","journal-title":"Iran J Pathol."},{"key":"ref516","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1164\/rccm.200408-1044SO","article-title":"Pathogen\u2013host interactions in Pseudomonas aeruginosa pneumonia","volume":"171","author":"Sadikot","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref517","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1099\/jmm.0.000521","article-title":"Evaluation of biofilm-specific antimicrobial resistance genes in Pseudomonas aeruginosa isolates in Farabi hospital","volume":"66","author":"Saffari","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref518","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jiph.2019.08.019","article-title":"Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in Central Pakistan","volume":"13","author":"Saleem","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref519","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/medicina59071215","article-title":"Antibiotic susceptibility surveillance in the Punjab Province of Pakistan: findings and implications","volume":"59","author":"Saleem","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"ref520","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2147\/IDR.S394777","article-title":"Pathogen burden among ICU patients in a tertiary care hospital in hail Saudi Arabia with particular reference to \u03b2-lactamases profile","volume":"16","author":"Saleem","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref521","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/diagnostics12071695","article-title":"Catheter-associated urinary tract infection in intensive care unit patients at a tertiary care hospital, hail, kingdom of Saudi Arabia","volume":"12","author":"Saleem","year":"2022","journal-title":"Diagnostics."},{"key":"ref522","doi-asserted-by":"publisher","first-page":"e132030","DOI":"10.5812\/archcid-132030","article-title":"Mortality and outcomes of patients infected with extensively drug-resistant Bacteria admitted to intensive care units","volume":"18","author":"Salimizand","year":"2023","journal-title":"Arch. Clin. Infect. Dis."},{"key":"ref523","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref524","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2217\/fmb.10.47","article-title":"Antimicrobial susceptibility of gram-negative nonurinary bacteria to fosfomycin and other antimicrobials","volume":"5","author":"Samonis","year":"2010","journal-title":"Future Microbiol."},{"key":"ref525","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s10096-012-1684-9","article-title":"Antimicrobial susceptibility of non-fermenting gram-negative isolates to isepamicin in a region with high antibiotic resistance","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref526","doi-asserted-by":"publisher","first-page":"dlab104","DOI":"10.1093\/jacamr\/dlab104","article-title":"Evaluation of rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance","volume":"3","author":"Sanchez-Lopez","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"ref527","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/antibiotics10070851","article-title":"Lower respiratory tract pathogens and their antimicrobial susceptibility pattern: a 5-year study","volume":"10","author":"Santella","year":"2021","journal-title":"Antibiotics"},{"key":"ref528","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7324\/JAPS.2020.102009","article-title":"The prevalence of colistin-resistant gram-negative bacteria isolated from hospitalized patients with bacteremia","volume":"10","author":"Santimaleeworagun","year":"2020","journal-title":"J. Appl. Pharmaceutical Sci."},{"key":"ref529","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0049475520979298","article-title":"Prevalence and antibiogram of non-fermenting gram-negative bacilli in blood stream infections: study in a tertiary care Centre, Western Uttar Pradesh, India","volume":"51","author":"Sarwat","year":"2021","journal-title":"Trop Doct."},{"key":"ref530","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s15010-022-01762-6","article-title":"Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility","volume":"50","author":"Schaumburg","year":"2022","journal-title":"Infection"},{"key":"ref531","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2011.05.010","article-title":"Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy","volume":"71","author":"Schechner","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref532","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/jac\/49.2.403","article-title":"In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany","volume":"49","author":"Sch\u00fclin","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref533","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1128\/jcm.9.1.72-78.1979","article-title":"Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients","volume":"9","author":"Seale","year":"1979","journal-title":"J. Clin. Microbiol."},{"key":"ref534","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/mdr.2013.0161","article-title":"Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012","volume":"20","author":"Sefraoui","year":"2014","journal-title":"Microb. Drug Resist."},{"key":"ref535","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijantimicag.2017.06.024","article-title":"In-vitro activity of ceftolozane\/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany","volume":"51","author":"Seifert","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref536","first-page":"1041","article-title":"In vitro synergistic efficacy of various antibiotic combinations against multi-drug-resistant Pseudomonas aeruginosa isolates obtained from patients in intensive care units","volume":"32","author":"\u015een","year":"2016","journal-title":"Acta Med. Austriaca"},{"key":"ref537","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/antibiotics11111511","article-title":"Comparative analysis of complicated urinary tract infections caused by extensively drug-resistant pseudomonas aeruginosa and extended-spectrum \u03b2-lactamase-producing klebsiella pneumoniae","volume":"11","author":"Sendra","year":"2022","journal-title":"Antibiotics"},{"key":"ref538","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10123-022-00256-7","article-title":"Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran","volume":"25","author":"Shahri","year":"2022","journal-title":"Int. Microbiol."},{"key":"ref539","doi-asserted-by":"publisher","first-page":"Dc20","DOI":"10.7860\/JCDR\/2016\/22607.9020","article-title":"Emergence of hospital acquired Carbapenem resistant non-fermenters in teaching institute","volume":"10","author":"Sharan","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref540","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nmni.2017.10.013","article-title":"Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran","volume":"21","author":"Shariati","year":"2018","journal-title":"New Microbes New Infect."},{"key":"ref541","doi-asserted-by":"publisher","first-page":"806","DOI":"10.22038\/ijbms.2019.35063.8340","article-title":"Prevalence of beta-lactamase genes, class 1 integrons, major virulence factors and clonal relationships of multidrug-resistant Pseudomonas aeruginosa isolated from hospitalized patients in southeast of Iran","volume":"22","author":"Sharifi","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref542","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12866-023-02906-w","article-title":"Detection of Bla(NDM-1,)mcr-1 and MexB in multidrug resistant Pseudomonas aeruginosa isolated from clinical specimens in a tertiary care hospital of Nepal","volume":"23","author":"Sharma","year":"2023","journal-title":"BMC Microbiol."},{"key":"ref543","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4315030","article-title":"Colistin resistance and management of drug resistant infections","volume":"2022","author":"Sharma","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref544","doi-asserted-by":"crossref","DOI":"10.33314\/jnhrc.v20i01.4142","volume-title":"Antibiotic susceptibility pattern of Bacteria causing urinary tract infection","author":"Sherchan","year":"2022"},{"key":"ref545","doi-asserted-by":"publisher","first-page":"661","DOI":"10.33314\/jnhrc.v18i4.2566","article-title":"Antimicrobial susceptibility pattern of gram-negative bacteria causing lower respiratory tract infections in Kathmandu university hospital","volume":"18","author":"Sherchan","year":"2020","journal-title":"J Nepal Health Res Counc"},{"key":"ref546","first-page":"991","article-title":"Antibiotic sensitivity pattern of bacterial isolates from the intensive care unit of a tertiary care hospital in India","volume":"11","author":"Sheth","year":"","journal-title":"Trop. J. Pharm. Res."},{"key":"ref547","first-page":"46","article-title":"Antibiotic sensitivity pattern in neonatal intensive care unit of a tertiary care hospital of India","volume":"5","author":"Sheth","year":"","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref548","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12866-023-02825-w","article-title":"Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among coronavirus disease-19 patients","volume":"23","author":"Shiralizadeh","year":"2023","journal-title":"BMC Microbiol."},{"key":"ref549","first-page":"80","article-title":"Imipenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from South India","volume":"15","author":"Shivshetty","year":"2020","journal-title":"Res. J. Biotechnol."},{"key":"ref550","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/jac\/dkab252","article-title":"Activity of meropenem\/vaborbactam and comparators against gram-negative isolates from eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014\u201319)","volume":"76","author":"Shortridge","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref551","doi-asserted-by":"publisher","first-page":"115302","DOI":"10.1016\/j.diagmicrobio.2020.115302","article-title":"Susceptibility trends of ceftolozane\/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018)","volume":"100","author":"Shortridge","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref552","doi-asserted-by":"publisher","first-page":"00465","DOI":"10.1128\/AAC.00465-17","article-title":"Ceftolozane-tazobactam activity against Pseudomonas aeruginosa clinical isolates from US hospitals: report from the PACTS antimicrobial surveillance program, 2012 to 2015","volume":"61","author":"Shortridge","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref553","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijantimicag.2019.01.015","article-title":"Activity of ceftolozane-tazobactam and comparators when tested against gram-negative isolates collected from paediatric patients in the USA and Europe between 2012 and 2016 as part of a global surveillance programme","volume":"53","author":"Shortridge","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref554","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","article-title":"Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY antimicrobial surveillance program, 1997-2016","volume":"6","author":"Shortridge","year":"","journal-title":"Open Forum Infect. Dis."},{"key":"ref555","doi-asserted-by":"publisher","first-page":"ofz240","DOI":"10.1093\/ofid\/ofz240","article-title":"Comparison of the in vitro susceptibility of Ceftolozane-Tazobactam with the cumulative susceptibility rates of standard antibiotic combinations when tested against Pseudomonas aeruginosa from ICU patients with bloodstream infections or pneumonia","volume":"6","author":"Shortridge","year":"","journal-title":"Open Forum Infect. Dis."},{"key":"ref556","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2018.05.011","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the program to assess Ceftolozane-Tazobactam susceptibility (PACTS) surveillance program","volume":"92","author":"Shortridge","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref557","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jgar.2019.10.009","article-title":"Antimicrobial activity of ceftolozane\/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme","volume":"21","author":"Shortridge","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref558","doi-asserted-by":"publisher","first-page":"e02712","DOI":"10.1128\/spectrum.02712-21","article-title":"In vitro activity of cefiderocol against US and European gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program","volume":"10","author":"Shortridge","year":"2022","journal-title":"Microbiol. Spectrum"},{"key":"ref559","doi-asserted-by":"publisher","first-page":"899","DOI":"10.22038\/IJBMS.2023.67981.14992","article-title":"Detection of quorum sensing virulence factor genes and its consanguinity to antibiotic sensitivity profile in the clinical isolates of Pseudomonas aeruginosa","volume":"26","author":"Shravani","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref560","doi-asserted-by":"publisher","first-page":"dlaa050","DOI":"10.1093\/jacamr\/dlaa050","article-title":"Impact of an antimicrobial stewardship programme on antimicrobial utilization and the prevalence of MDR Pseudomonas aeruginosa in an acute care hospital in Qatar","volume":"2","author":"Sid Ahmed","year":"2020","journal-title":"JAC Antimicrob. Resist."},{"key":"ref561","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1093\/jac\/dkz379","article-title":"Evaluation of in vitro activity of ceftazidime\/avibactam and ceftolozane\/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar","volume":"74","author":"Sid Ahmed","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref562","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1080\/07853890.2021.2012588","article-title":"Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar","volume":"53","author":"Sid Ahmed","year":"2021","journal-title":"Ann. Med."},{"key":"ref563","doi-asserted-by":"publisher","first-page":"dlad086","DOI":"10.1093\/jacamr\/dlad086","article-title":"The epidemiology and microbiological characteristics of infections caused by gram-negative bacteria in Qatar: national surveillance from the study for monitoring of antimicrobial resistance trends (SMART): 2017 to 2019","volume":"5","author":"Sid Ahmed","year":"2023","journal-title":"JAC Antimicrob. Resist."},{"key":"ref564","first-page":"239","article-title":"Colistin and polymyxin B minimal inhibitory concentrations determined by Etest found unreliable for gram-negative bacilli","volume":"17","author":"Simar","year":"2017","journal-title":"Ochsner J."},{"key":"ref565","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4103\/ijmm.IJMM_20_3","article-title":"The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India","volume":"37","author":"Singhal","year":"2019","journal-title":"Indian J Med Microbiol."},{"key":"ref566","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3855\/jidc.9539","article-title":"Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa","volume":"12","author":"Singh-Moodley","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref567","doi-asserted-by":"publisher","first-page":"1001476","DOI":"10.3389\/fmed.2023.1001476","article-title":"The under investigated facet of the COVID-19 pandemic: molecular analysis of secondary bacterial infections at a COVID dedicated intensive care unit within a tertiary care center in Lebanon","volume":"10","author":"Sleiman","year":"2023","journal-title":"Front. Med."},{"key":"ref568","doi-asserted-by":"publisher","first-page":"104065","DOI":"10.1016\/j.meegid.2019.104065","article-title":"Genetic analysis of carbapenemase-producing gram-negative bacteria isolated from a university teaching hospital in Egypt","volume":"77","author":"Soliman","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref569","doi-asserted-by":"publisher","first-page":"e39243","DOI":"10.7759\/cureus.39243","article-title":"Emergence of multidrug-resistant non-fermenting gram-negative Bacilli in a tertiary care teaching Hospital of Central India: is Colistin resistance still a distant threat?","volume":"15","author":"Soni","year":"2023","journal-title":"Cureus"},{"key":"ref570","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/jac\/dkaa089","article-title":"In vitro activity of ceftazidime\/avibactam and comparators against gram-negative bacterial isolates collected from Latin American centres between 2015 and 2017","volume":"75","author":"Stone","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref571","doi-asserted-by":"publisher","first-page":"114835","DOI":"10.1016\/j.diagmicrobio.2019.05.007","article-title":"Longitudinal analysis of the in vitro activity of ceftazidime-avibactam vs. Pseudomonas aeruginosa, 2012-2016","volume":"96","author":"Stone","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref572","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jgar.2021.04.019","article-title":"In vitro activity of cefiderocol and comparators against isolates of gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in Italy","volume":"25","author":"Stracquadanio","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref573","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref574","doi-asserted-by":"publisher","first-page":"02397","DOI":"10.1128\/AAC.02397-18","article-title":"Molecular characterization of multidrug-resistant Pseudomonas aeruginosa isolates in hospitals in Myanmar","volume":"63","author":"Tada","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref575","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1471-2334-13-251","article-title":"Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam","volume":"13","author":"Tada","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref576","doi-asserted-by":"publisher","first-page":"100853","DOI":"10.1016\/j.genrep.2020.100853","article-title":"Prevalence and molecular typing of Metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa with adhesion factors: a descriptive analysis of burn wounds isolates from Iran","volume":"21","author":"Tahmasebi","year":"","journal-title":"Gene Reports"},{"key":"ref577","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.2147\/IDR.S264796","article-title":"Prevalence and molecular typing of Colistin-resistant Pseudomonas aeruginosa (CRPA) among beta-lactamase-producing isolates: a study based on high-resolution melting curve analysis method","volume":"13","author":"Tahmasebi","year":"","journal-title":"Infect Drug Resist."},{"key":"ref578","doi-asserted-by":"publisher","first-page":"104518","DOI":"10.1016\/j.meegid.2020.104518","article-title":"Co-harboring of mcr-1 and \u03b2-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): molecular typing of superbug strains in bloodstream infections (BSI)","volume":"85","author":"Tahmasebi","year":"","journal-title":"Infect. Genet. Evol."},{"key":"ref579","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jgar.2021.07.003","article-title":"Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal","volume":"26","author":"Takahashi","year":"2021","journal-title":"J Glob Antimicrob Resist."},{"key":"ref580","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3855\/jidc.17791","article-title":"Pre-and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital","volume":"17","author":"Taleb","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref581","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12668-019-00658-4","article-title":"World health organization report: current crisis of antibiotic resistance","volume":"9","author":"Talebi Bezmin Abadi","year":"2019","journal-title":"BioNanoScience"},{"key":"ref582","doi-asserted-by":"publisher","first-page":"e93651","DOI":"10.5812\/archcid.93651","article-title":"Survey on some carbapenems and colistin resistance genes among Pseudomonas aeruginosa isolates from burn and cystic fibrosis patients, Tehran, Iran. Archives of","volume":"14","author":"Talebi","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref583","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/jac\/dkl330","article-title":"Comparison of three standardized disc susceptibility testing methods for colistin","volume":"58","author":"Tan","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref584","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/antibiotics11060732","article-title":"In vitro activity of ceftolozane-tazobactam and other antibiotics against Pseudomonas aeruginosa infection-isolates from an academic medical center in Thailand","volume":"11","author":"Tantisiriwat","year":"2022","journal-title":"Antibiotics."},{"key":"ref585","doi-asserted-by":"publisher","first-page":"e39036","DOI":"10.5812\/archcid.39036","article-title":"Phenotypic and molecular detection of metallo-beta-lactamase genes among imipenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients with burn injuries. Archives of","volume":"11","author":"Tarashi","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref586","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/jac\/dkab186","article-title":"A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing gram-negative bacteria in the UK","volume":"76","author":"Taylor","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref587","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.burns.2021.03.005","article-title":"Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients","volume":"47","author":"Tchakal-Mesbahi","year":"2021","journal-title":"Burns"},{"key":"ref588","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pedneo.2013.03.011","article-title":"A 4-year surveillance of device-associated nosocomial infections in a neonatal intensive care unit","volume":"54","author":"Tekin","year":"2013","journal-title":"Pediatr. Neonatol."},{"key":"ref589","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","article-title":"Carbapenemase-producing Pseudomonas aeruginosa-an emerging challenge","volume":"11","author":"Tenover","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref590","doi-asserted-by":"publisher","first-page":"958","DOI":"10.21608\/mid.2022.150919.1352","article-title":"Emergence of Colistin-resistant Pseudomonas aeruginasa in Sohag University hospitals, Egypt","author":"Thabet","year":"2022","journal-title":"Microbes and Infectious Diseases."},{"key":"ref591","doi-asserted-by":"publisher","first-page":"20230824","DOI":"10.1515\/med-2023-0824","article-title":"Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease","volume":"18","author":"Thapa","year":"2023","journal-title":"Open Med."},{"key":"ref592","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jgar.2021.10.029","article-title":"In vitro activity of cefiderocol against gram-negative bacterial pathogens in Germany","volume":"28","author":"Thelen","year":"2022","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref593","article-title":"Comparative in vitro activity of Sitafloxacin against Bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections in 2016","volume":"100","author":"Tiengrim","year":"2017","journal-title":"J. Med. Assoc. Thail."},{"key":"ref594","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2147\/IDR.S163293","article-title":"Prevalence of multidrug-resistant gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations","volume":"11","author":"Tohamy","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref595","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00701-016-2890-5","article-title":"Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence","volume":"158","author":"Tsitsopoulos","year":"2016","journal-title":"Acta Neurochir."},{"key":"ref596","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00134-013-2828-9","article-title":"Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients","volume":"39","author":"Tumbarello","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref597","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1017\/S0950268810003055","article-title":"Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality","volume":"139","author":"Tumbarello","year":"2011","journal-title":"Epidemiol. Infect."},{"key":"ref598","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bjid.2020.04.004","article-title":"Evaluation of in vitro activity of ceftolozane-tazobactam against recent clinical bacterial isolates from Brazil \u2013 the EM200 study","volume":"24","author":"Tuon","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"ref599","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3855\/jidc.17580","article-title":"Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds","volume":"17","author":"Ullah","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref600","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5152\/cjms.2019.931","article-title":"Isolation, identification, and antibiotic susceptibility patterns of Pseudomonas aeruginosa strains from various clinical samples in a University Hospital in Northern Cyprus","volume":"4","author":"Ullah","year":"2019","journal-title":"Cyprus J. Med. Sci."},{"key":"ref601","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3855\/jidc.12599","article-title":"Antibacterial resistance in lower respiratory tract bacterial pathogens: a multicenter analysis from Turkey","volume":"15","author":"Uskudar Guclu","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref602","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5505\/TurkHijyen.2014.68916","article-title":"Changes in resistance percentage to antibiotics in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from blood cultures of intensive care unit patients","volume":"71","author":"Uzun","year":"2014","journal-title":"Turk Hij Den Biyol Derg."},{"key":"ref603","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3109\/00365548.2010.509333","article-title":"Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment","volume":"42","author":"Valenza","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"ref604","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jcf.2007.06.006","article-title":"Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis","volume":"7","author":"Valenza","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref605","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3109\/23744235.2015.1031171","article-title":"Prevalence, antimicrobial susceptibility, and genetic diversity of Pseudomonas aeruginosa as intestinal colonizer in the community","volume":"47","author":"Valenza","year":"2015","journal-title":"Infect Dis."},{"key":"ref606","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.22207\/JPAM.17.4.06","article-title":"Efficacy of Colistin with Carbapenems combination by checkerboard assay against Carbapenem resistant non lactose fermenting gram negative Bacteria. Journal of Pure & Applied","volume":"17","author":"Vamsi","year":"2023","journal-title":"Microbiology"},{"key":"ref607","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/IDR.S402278","article-title":"Distribution and antibiotic resistance characteristics of bacteria isolated from blood culture in a teaching hospital in Vietnam during 2014\u20132021","volume":"16","author":"Van An","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref608","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/mdr.2018.0036","article-title":"PME and other ESBL-positive multiresistant Pseudomonas aeruginosa isolated from hospitalized patients in the region of Kurdistan, Iraq","volume":"25","author":"van Burgh","year":"2019","journal-title":"Microbial Drug Resist."},{"key":"ref609","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-0711-6-8","article-title":"Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins","volume":"6","author":"van der Heijden","year":"2007","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref610","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2049936116666983","article-title":"Bloodstream infections and antimicrobial sensitivity patterns in a tertiary care hospital of India","volume":"3","author":"Vasudeva","year":"2016","journal-title":"Therap. Adv. Infect. Dis."},{"key":"ref611","doi-asserted-by":"publisher","first-page":"115","DOI":"10.37897\/RJID.2018.3.4","article-title":"Pseudomonas Aeruginosa infections in the \u201cSf\u00e2nta Parascheva\u201d infectious diseases hospital of Iasi city","volume":"21","author":"Vata","year":"2018","journal-title":"Romanian J. Infect. Dis."},{"key":"ref612","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/ijmm.IJMM_17_415","article-title":"Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: study for monitoring antimicrobial resistance trend report","volume":"36","author":"Veeraraghavan","year":"2018","journal-title":"Indian J. Med. Microbiol."},{"key":"ref613","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","article-title":"Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection","volume":"26","author":"Viasus","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref614","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3201\/eid1808.111234","article-title":"VIM-2\u2013producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain","volume":"18","author":"Viedma","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"ref615","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.resmic.2007.02.003","article-title":"High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic","volume":"158","author":"Vosahlikova","year":"2007","journal-title":"Res. Microbiol."},{"key":"ref616","first-page":"274","article-title":"Nosocomial infection by non-fermenting gram negative bacilli in tertiary care hospital: screening and cure","volume":"8","author":"Wadhwa","year":"2016","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref617","volume-title":"Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline","author":"Waites","year":"2011"},{"key":"ref618","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2012.05.007","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008\u20132011","volume":"73","author":"Walkty","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref619","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1128\/AAC.01696-10","article-title":"In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study)","volume":"55","author":"Walkty","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref620","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1128\/AAC.00786-09","article-title":"In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008","volume":"53","author":"Walkty","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref621","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1128\/AAC.01404-13","article-title":"In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012","volume":"57","author":"Walkty","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref622","doi-asserted-by":"publisher","first-page":"dlac122","DOI":"10.1093\/jacamr\/dlac122","article-title":"Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020","volume":"4","author":"Walkty","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref623","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.diagmicrobio.2016.10.003","article-title":"Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: results of the Canadian Ward surveillance study (CANWARD), 2008-2015","volume":"87","author":"Walkty","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref624","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3201\/eid2507.181200","article-title":"Carbapenem-resistant Pseudomonas aeruginosa at US emerging infections program sites, 2015","volume":"25","author":"Walters","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref625","doi-asserted-by":"publisher","first-page":"1020652","DOI":"10.3389\/fmicb.2022.1020652","article-title":"Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref626","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1515\/labmed-2019-0162","article-title":"Prevalence of metallo-\u03b2-lactamase genes among Pseudomonas aeruginosa isolated from various clinical samples in China","volume":"44","author":"Wang","year":"2020","journal-title":"J. Lab. Med."},{"key":"ref627","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2147\/IDR.S253104","article-title":"Long-term continuous antimicrobial resistance surveillance among nosocomial gram-negative Bacilli in China from 2010 to 2018 (CMSS)","volume":"13","author":"Wang","year":"2020","journal-title":"Infect Drug Resist."},{"key":"ref628","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4103\/ijmm.IJMM_20_92","article-title":"Performance of three commercial assays for colistin susceptibility in clinical isolates and mcr-1 carrying reference strain","volume":"37","author":"Wattal","year":"2019","journal-title":"Indian J. Med. Microbiol."},{"key":"ref629","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bjid.2013.07.010","article-title":"Ecology of blood stream infection and antibiotic resistance in intensive care unit at a tertiary care hospital in North India","volume":"18","author":"Wattal","year":"2014","journal-title":"Braz. J. Infect. Dis."},{"key":"ref630","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0033-3506(83)80004-3","article-title":"Prevalence and antimicrobial sensitivity of Localpseudomonas aeruginosa at a teaching hospital","volume":"97","author":"Wemambu","year":"1983","journal-title":"Public Health"},{"key":"ref631","doi-asserted-by":"publisher","first-page":"dlac057","DOI":"10.1093\/jacamr\/dlac057","article-title":"Genomic-based transmission analysis of carbapenem-resistant Pseudomonas aeruginosa at a tertiary care Centre in Cologne (Germany) from 2015 to 2020","volume":"4","author":"Wendel","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref632","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ijantimicag.2017.01.023","article-title":"Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea","volume":"49","author":"Wi","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref633","doi-asserted-by":"publisher","first-page":"01970","DOI":"10.1128\/AAC.01970-17","article-title":"Activity of ceftolozane-tazobactam against carbapenem-resistant, non-carbapenemase-producing Pseudomonas aeruginosa and associated resistance mechanisms","volume":"62","author":"Wi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref634","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jac\/dku546","article-title":"Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study","volume":"70","author":"Willmann","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref635","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-515","article-title":"Effect of metallo-\u03b2-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study","volume":"13","author":"Willmann","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref636","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jgar.2023.08.022","article-title":"In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS global surveillance program 2017\u20132021","volume":"35","author":"Wise","year":"","journal-title":"J. Global Antimicrobial Resist."},{"key":"ref637","doi-asserted-by":"publisher","first-page":"102759","DOI":"10.1016\/j.bjid.2023.102759","article-title":"Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015\u20132020","volume":"27","author":"Wise","year":"","journal-title":"Braz. J. Infect. Dis."},{"key":"ref638","doi-asserted-by":"publisher","first-page":"829592","DOI":"10.3389\/fcimb.2022.829592","article-title":"In vitro activity of MRX-8 and comparators against clinical isolated gram-negative bacilli in China","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref639","doi-asserted-by":"publisher","first-page":"1017488","DOI":"10.3389\/fmicb.2022.1017488","article-title":"Antimicrobial susceptibility to polymyxin B and other comparators against gram-negative bacteria isolated from bloodstream infections in China: results from CARVIS-NET program","volume":"13","author":"Xi","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref640","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13104-020-05163-6","article-title":"Emergence of multidrug-resistant non-fermentative gram negative bacterial infection in hospitalized patients in a tertiary care center of Nepal","volume":"13","author":"Yadav","year":"2020","journal-title":"BMC. Res. Notes"},{"key":"ref641","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/cryst12081057","article-title":"Synergistic antibacterial activity of green synthesized silver nanomaterials with colistin antibiotic against multidrug-resistant bacterial pathogens","volume":"12","author":"Yassin","year":"2022","journal-title":"Crystals"},{"key":"ref642","doi-asserted-by":"publisher","first-page":"e0139836","DOI":"10.1371\/journal.pone.0139836","article-title":"Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single University Hospital Center in Germany over a 10-year period","volume":"10","author":"Yayan","year":"2015","journal-title":"PLoS One"},{"key":"ref643","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00284-023-03443-5","article-title":"Efficacy of Ceragenins alone and in combinations with antibiotics against multidrug-resistant gram negative pathogens from bloodstream infections","volume":"80","author":"Yilmaz","year":"2023","journal-title":"Curr. Microbiol."},{"key":"ref644","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1099\/jmm.0.000401","article-title":"Individualized antibiotic therapy in patients with ventilator-associated pneumonia","volume":"66","author":"Yilmaz","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref645","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1600-0463.2012.02948.x","article-title":"A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spreading in a burn unit in Orumieh","volume":"121","author":"Yousefi","year":"2013","journal-title":"Iran. Apmis."},{"key":"ref646","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1179\/1973947814Y.0000000220","article-title":"Multicentric study in five African countries of antibiotic susceptibility for three main pathogens: Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa","volume":"28","author":"Zerouali","year":"2016","journal-title":"J. Chemother."},{"key":"ref647","doi-asserted-by":"publisher","first-page":"iv5","DOI":"10.1093\/jac\/dkz283","article-title":"42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study","volume":"74","author":"Zhanel","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref648","doi-asserted-by":"publisher","first-page":"i7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007\u201311 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref649","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.diagmicrobio.2010.10.025","article-title":"Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007\u20132009 study","volume":"69","author":"Zhanel","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref650","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward surveillance study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref651","doi-asserted-by":"publisher","first-page":"e0123121","DOI":"10.1128\/Spectrum.01231-21","article-title":"Combining Colistin with Furanone C-30 rescues Colistin resistance of gram-negative Bacteria in vitro and in vivo","volume":"9","author":"Zhang","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref652","doi-asserted-by":"publisher","first-page":"e04261","DOI":"10.1128\/spectrum.04261-22","article-title":"Epidemiological and genetic characteristics of clinical carbapenem-resistant Pseudomonas aeruginosa strains in Guangdong Province, China","volume":"11","author":"Zhao","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref653","doi-asserted-by":"publisher","first-page":"e00787","DOI":"10.1128\/mSystems.00787-21","article-title":"Emergence of ceftazidime-and avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Pseudomonas aeruginosa in China","volume":"6","author":"Zhu","year":"2021","journal-title":"Msystems"},{"key":"ref654","doi-asserted-by":"publisher","first-page":"e00105","DOI":"10.1128\/spectrum.00105-23","article-title":"Emergence of ST463 exoU-positive, imipenem-nonsusceptible Pseudomonas aeruginosa isolates in China","volume":"11","author":"Zhu","year":"2023","journal-title":"Microbiol. Spectrum."},{"key":"ref655","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5001\/omj.2015.54","article-title":"Prevalence of device-associated nosocomial infections caused by gram-negative bacteria in a trauma intensive care unit in Libya","volume":"30","author":"Zorgani","year":"2015","journal-title":"Oman Med. J."},{"key":"ref656","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/njcp.njcp_229_17","article-title":"Resistance pattern and detection of metallo-beta-lactamase genes in clinical isolates of Pseudomonas aeruginosa in a Central Nigeria tertiary hospital","volume":"21","author":"Zubair","year":"2018","journal-title":"Niger. J. Clin. Pract."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1477836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:13:48Z","timestamp":1732868028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1477836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":656,"alternative-id":["10.3389\/fmicb.2024.1477836"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1477836","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"article-number":"1477836"}}